<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:02:13Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5017906" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5017906</identifier><datestamp>2017-02-07</datestamp><setSpec>blackwellopen</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Neurochem</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Neurochem</journal-id>
      <journal-id journal-id-type="doi">10.1111/(ISSN)1471-4159</journal-id>
      <journal-id journal-id-type="publisher-id">JNC</journal-id>
      <journal-title-group>
        <journal-title>Journal of Neurochemistry</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0022-3042</issn>
      <issn pub-type="epub">1471-4159</issn>
      <publisher>
        <publisher-name>John Wiley and Sons Inc.</publisher-name>
        <publisher-loc>Hoboken</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5017906</article-id>
      <article-id pub-id-type="pmcid">PMC5017906</article-id>
      <article-id pub-id-type="pmc-uid">5017906</article-id>
      <article-id pub-id-type="pmid">27344019</article-id>
      <article-id pub-id-type="doi">10.1111/jnc.13718</article-id>
      <article-id pub-id-type="publisher-id">JNC13718</article-id>
      <article-categories>
        <subj-group subj-group-type="overline">
          <subject>Original Article</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>ORIGINAL ARTICLES</subject>
          <subj-group subj-group-type="heading">
            <subject>Signal Transduction &amp; Synaptic Transmission</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Functional interaction between Lypd6 and nicotinic acetylcholine receptors</article-title>
        <alt-title alt-title-type="left-running-head">M. Arvaniti <italic>etÂ al</italic>.</alt-title>
      </title-group>
      <contrib-group>
        <contrib id="jnc13718-cr-0001" contrib-type="author">
          <name>
            <surname>Arvaniti</surname>
            <given-names>Maria</given-names>
          </name>
          <xref ref-type="aff" rid="jnc13718-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="jnc13718-cr-0002" contrib-type="author">
          <name>
            <surname>Jensen</surname>
            <given-names>Majbrit M.</given-names>
          </name>
          <xref ref-type="aff" rid="jnc13718-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="jnc13718-cr-0003" contrib-type="author">
          <name>
            <surname>Soni</surname>
            <given-names>Neeraj</given-names>
          </name>
          <xref ref-type="aff" rid="jnc13718-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="jnc13718-cr-0004" contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Hong</given-names>
          </name>
          <xref ref-type="aff" rid="jnc13718-aff-0003">
<sup>3</sup>
</xref>
        </contrib>
        <contrib id="jnc13718-cr-0005" contrib-type="author">
          <name>
            <surname>Klein</surname>
            <given-names>Anders B.</given-names>
          </name>
          <xref ref-type="aff" rid="jnc13718-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="jnc13718-cr-0006" contrib-type="author">
          <name>
            <surname>Thiriet</surname>
            <given-names>Nathalie</given-names>
          </name>
          <xref ref-type="aff" rid="jnc13718-aff-0004">
<sup>4</sup>
</xref>
        </contrib>
        <contrib id="jnc13718-cr-0007" contrib-type="author">
          <name>
            <surname>Pinborg</surname>
            <given-names>Lars H.</given-names>
          </name>
          <xref ref-type="aff" rid="jnc13718-aff-0002">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="jnc13718-aff-0005">
<sup>5</sup>
</xref>
        </contrib>
        <contrib id="jnc13718-cr-0008" contrib-type="author">
          <name>
            <surname>Muldoon</surname>
            <given-names>Pretal P.</given-names>
          </name>
          <xref ref-type="aff" rid="jnc13718-aff-0006">
<sup>6</sup>
</xref>
        </contrib>
        <contrib id="jnc13718-cr-0009" contrib-type="author">
          <name>
            <surname>Wienecke</surname>
            <given-names>Jacob</given-names>
          </name>
          <xref ref-type="aff" rid="jnc13718-aff-0007">
<sup>7</sup>
</xref>
        </contrib>
        <contrib id="jnc13718-cr-0010" contrib-type="author">
          <name>
            <surname>Imad Damaj</surname>
            <given-names>M.</given-names>
          </name>
          <xref ref-type="aff" rid="jnc13718-aff-0006">
<sup>6</sup>
</xref>
        </contrib>
        <contrib id="jnc13718-cr-0011" contrib-type="author">
          <name>
            <surname>Kohlmeier</surname>
            <given-names>Kristi A.</given-names>
          </name>
          <xref ref-type="aff" rid="jnc13718-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="jnc13718-cr-0012" contrib-type="author">
          <name>
            <surname>GondrÃ©âLewis</surname>
            <given-names>Marjorie C.</given-names>
          </name>
          <xref ref-type="aff" rid="jnc13718-aff-0003">
<sup>3</sup>
</xref>
        </contrib>
        <contrib id="jnc13718-cr-0013" contrib-type="author">
          <name>
            <surname>Mikkelsen</surname>
            <given-names>Jens D.</given-names>
          </name>
          <xref ref-type="aff" rid="jnc13718-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="jnc13718-cr-0014" contrib-type="author" corresp="yes">
          <name>
            <surname>Thomsen</surname>
            <given-names>Morten S.</given-names>
          </name>
          <address>
            <email>morten.s.thomsen@sund.ku.dk</email>
          </address>
          <xref ref-type="aff" rid="jnc13718-aff-0001">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="jnc13718-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="jnc13718-aff-0001">
        <label>
          <sup>1</sup>
        </label>
        <named-content content-type="organisation-division">Department of Drug Design &amp; Pharmacology</named-content>
        <institution>University of Copenhagen</institution>
        <named-content content-type="city">Copenhagen</named-content>
        <country country="DK">Denmark</country>
      </aff>
      <aff id="jnc13718-aff-0002">
        <label>
          <sup>2</sup>
        </label>
        <institution>Neurobiology Research Unit</institution>
        <institution>University Hospital Copenhagen</institution>
        <named-content content-type="city">Rigshospitalet</named-content>
        <named-content content-type="country-part">Copenhagen</named-content>
        <country country="DK">Denmark</country>
      </aff>
      <aff id="jnc13718-aff-0003">
        <label>
          <sup>3</sup>
        </label>
        <institution>Laboratory for Neurodevelopment</institution>
        <institution>Department of Anatomy</institution>
        <institution>Howard University College of Medicine</institution>
        <named-content content-type="city">Washington</named-content>
        <named-content content-type="country-part">District of Columbia</named-content>
        <country country="US">USA</country>
      </aff>
      <aff id="jnc13718-aff-0004">
        <label>
          <sup>4</sup>
        </label>
        <institution>Laboratory of Experimental and Clinical Neurosciences</institution>
        <institution>University of Poitiers</institution>
        <named-content content-type="city">Poitiers</named-content>
        <country country="FR">France</country>
      </aff>
      <aff id="jnc13718-aff-0005">
        <label>
          <sup>5</sup>
        </label>
        <institution>Epilepsy Clinic</institution>
        <institution>University Hospital Copenhagen</institution>
        <named-content content-type="city">Rigshospitalet</named-content>
        <named-content content-type="country-part">Copenhagen</named-content>
        <country country="DK">Denmark</country>
      </aff>
      <aff id="jnc13718-aff-0006">
        <label>
          <sup>6</sup>
        </label>
        <named-content content-type="organisation-division">Department of Pharmacology and Toxicology</named-content>
        <institution>Medical College of Virginia</institution>
        <institution>Virginia Commonwealth University</institution>
        <named-content content-type="city">Richmond</named-content>
        <named-content content-type="country-part">Virginia</named-content>
        <country country="US">USA</country>
      </aff>
      <aff id="jnc13718-aff-0007">
        <label>
          <sup>7</sup>
        </label>
        <named-content content-type="organisation-division">Department of Nutrition</named-content>
        <institution>Exercise and Sport &amp; Department of Neuroscience and Pharmacology</institution>
        <institution>University of Copenhagen</institution>
        <named-content content-type="city">Copenhagen</named-content>
        <country country="DK">Denmark</country>
      </aff>
      <author-notes>
        <corresp id="correspondenceTo"><label>*</label>Address correspondence and reprint requests to Morten SkÃ¸tt Thomsen, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Jagtvej 160, building 22, C.421, 2100 Copenhagen, Denmark. Eâmail: <email>morten.s.thomsen@sund.ku.dk</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>15</day>
        <month>8</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2016</year>
      </pub-date>
      <volume>138</volume>
      <issue>6</issue>
      <issue-id pub-id-type="doi">10.1111/jnc.2016.138.issue-6</issue-id>
      <fpage>806</fpage>
      <lpage>820</lpage>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>3</month>
          <year>2016</year>
        </date>
        <date date-type="rev-recd">
          <day>22</day>
          <month>6</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>6</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2016 International Society for Neurochemistry <copyright-statement>-->
        <copyright-statement content-type="article-copyright">Â© 2016 The Authors. <italic>Journal of Neurochemistry</italic> published by John Wiley &amp; Sons Ltd on behalf of International Society for Neurochemistry</copyright-statement>
        <license license-type="creativeCommonsBy">
          <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:JNC-138-806.pdf"/>
      <abstract id="jnc13718-abs-0001">
        <title>Abstract</title>
        <sec id="jnc13718-sec-1001">
          <p>Nicotinic acetylcholine receptors (<styled-content style="fixed-case">nAChR</styled-content>s) affect multiple physiological functions in the brain and their functions are modulated by regulatory proteins of the Lynx family. Here, we report for the first time a direct interaction of the Lynx protein <styled-content style="fixed-case">LY</styled-content>6/<styled-content style="fixed-case">PLAUR</styled-content> domainâcontaining 6 (Lypd6) with <styled-content style="fixed-case">nAChR</styled-content>s in human brain extracts, identifying Lypd6 as a novel regulator of <styled-content style="fixed-case">nAChR</styled-content> function. Using protein crossâlinking and affinity purification from human temporal cortical extracts, we demonstrate that Lypd6 is a synaptically enriched membraneâbound protein that binds to multiple <styled-content style="fixed-case">nAChR</styled-content> subtypes in the human brain. Additionally, soluble recombinant Lypd6 protein attenuates nicotineâinduced hippocampal inward currents in rat brain slices and decreases nicotineâinduced extracellular signalâregulated kinase phosphorylation in <styled-content style="fixed-case">PC</styled-content>12 cells, suggesting that binding of Lypd6 is sufficient to inhibit <styled-content style="fixed-case">nAChR</styled-content>âmediated intracellular signaling. We further show that perinatal nicotine exposure in rats (4Â mg/kg/day through minipumps to dams from embryonic day 7 to postânatal day 21) significantly increases Lypd6 protein levels in the hippocampus in adulthood, which did not occur after exposure to nicotine in adulthood only. Our findings suggest that Lypd6 is a versatile inhibitor of cholinergic signaling in the brain, and that Lypd6 is dysregulated by nicotine exposure during early development.</p>
        </sec>
        <sec id="jnc13718-sec-1002">
          <p>
<boxed-text position="anchor" content-type="graphic" id="jnc13718-blkfxd-0002" orientation="portrait"><graphic xlink:href="JNC-138-806-g008.jpg" position="anchor" id="nlm-graphic-1" orientation="portrait"/></boxed-text>
Regulatory proteins of the Lynx family modulate the function of nicotinic receptors (nAChRs). We report for the first time that the Lynx protein Lypd6 binds to nAChRs in human brain extracts, and that recombinant Lypd6 decreases nicotineâinduced ERK phosphorylation and attenuates nicotineâinduced hippocampal inward currents. Our findings suggest that Lypd6 is a versatile inhibitor of cholinergic signaling in the brain.</p>
        </sec>
      </abstract>
      <kwd-group kwd-group-type="author-generated">
        <kwd id="jnc13718-kwd-0001">affinity purification</kwd>
        <kwd id="jnc13718-kwd-0002">Lyâ6</kwd>
        <kwd id="jnc13718-kwd-0003"><styled-content style="fixed-case">LY</styled-content>6/<styled-content style="fixed-case">PLAUR</styled-content> domainâcontaining 6</kwd>
        <kwd id="jnc13718-kwd-0004">Lynx</kwd>
        <kwd id="jnc13718-kwd-0005">nicotine</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>Danish Ministry of Science, Innovation and Higher Education</funding-source>
          <award-id>DFFâ4183â00246</award-id>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>The Augustinus Foundation</funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>Agnes and Pouls Friis Foundation</funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>Fonden til LÃ¦gemiddelvidenskabens Fremme</funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>Danish Strategic Research Council (COGNITO)</funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>Danish Council for Independent Research</funding-source>
          <award-id>DFFâ4183â00246</award-id>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>The Danish Ministry of Culture</funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>Lundbeck Foundation</funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>National Institute of Neurological Disorders and Stroke</funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>National Institutes of Health (NIH)</funding-source>
          <award-id>NS65035</award-id>
          <award-id>AA021262</award-id>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>National Institute of Alcohol Abuse and Alcoholism (NIAAA)</funding-source>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="7"/>
        <table-count count="0"/>
        <page-count count="15"/>
        <word-count count="10762"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>source-schema-version-number</meta-name>
          <meta-value>2.0</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>component-id</meta-name>
          <meta-value>jnc13718</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>September 2016</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>details-of-publishers-convertor</meta-name>
          <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.0.2 mode:remove_FC converted:25.01.2017</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <def-list list-content="abbreviations" id="jnc13718-dl-0001">
      <title>Abbreviations used</title>
      <def-item>
        <term>ACSF</term>
        <def>
          <p>artificial cerebrospinal fluid</p>
        </def>
      </def-item>
      <def-item>
        <term>FC</term>
        <def>
          <p>frontal cortex</p>
        </def>
      </def-item>
      <def-item>
        <term>GPI</term>
        <def>
          <p>glycosylphosphatidylinositol</p>
        </def>
      </def-item>
      <def-item>
        <term>HIP</term>
        <def>
          <p>Hippocampus</p>
        </def>
      </def-item>
      <def-item>
        <term>KO</term>
        <def>
          <p>knockout</p>
        </def>
      </def-item>
      <def-item>
        <term>WT</term>
        <def>
          <p>wildâtype</p>
        </def>
      </def-item>
    </def-list>
    <p>Members of the Lyâ6/neurotoxin (Lynx) superfamily have been used for decades as lymphocyte differentiation markers (Bamezai <xref rid="jnc13718-bib-0006" ref-type="ref">2004</xref>). More recent research has shown that several Lynx proteins are expressed in the brain [reviewed in (Miwa <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0038" ref-type="ref">2012</xref>)]. Lynx proteins are characterized by a threeâdimensional consensus motif, termed the threeâfinger fold, that mediates proteinâprotein binding (Tsetlin <xref rid="jnc13718-bib-0055" ref-type="ref">1999</xref>), and most Lynx proteins are attached on the cell membrane through a glycosylphosphatidylinositol (GPI) anchor (Adermann <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0003" ref-type="ref">1999</xref>). The Lynx proteins, Lynx1 and Lynx2, have been shown to form stable complexes with, and negatively modulate the response of, Î±7 and Î±4Î²2 nicotinic acetylcholine receptors (nAChRs) (Miwa <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0035" ref-type="ref">2006</xref>; Tekinay <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0051" ref-type="ref">2009</xref>; Fu <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0019" ref-type="ref">2012</xref>). Furthermore, Lynx1 knockout mice exhibit improved associative learning in a fearâconditioning paradigm (Miwa <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0035" ref-type="ref">2006</xref>), and it was recently shown that Lynx1, acting through nAChRs, is critical for the loss of synaptic plasticity in the visual cortex that occurs in adulthood (Morishita <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0039" ref-type="ref">2010</xref>). These results suggest that Lynx1 can bind to and modulate nAChR function in the brain, and that this has important consequences for synaptic plasticity and memory [reviewed in (Miwa <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0037" ref-type="ref">2011</xref>, <xref rid="jnc13718-bib-0038" ref-type="ref">2012</xref>; Thomsen and Mikkelsen <xref rid="jnc13718-bib-0052" ref-type="ref">2012</xref>;Thomsen <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0500" ref-type="ref">2016</xref>)]. However, it is currently not known whether this regulation of the cholinergic system is unique to Lynx1 or whether it extends to other members of the Lynx family.</p>
    <p>LY6/PLAUR domainâcontaining 6 (Lypd6) is a Lynx protein that is expressed in the human and rodent nervous system (Darvas <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0014" ref-type="ref">2009</xref>; Zhang <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0062" ref-type="ref">2010</xref>). In the mouse visual cortex, Lypd6 and Lynx1 are mainly expressed in GABAergic interneurons, where they exhibit complementary expression patterns; the former is exclusively expressed in somatostatin and the latter is restricted in parvalbumin interneurons (Demars and Morishita <xref rid="jnc13718-bib-0015" ref-type="ref">2014</xref>). This implies that Lypd6 may be involved in modulation of nAChRs in neuronal circuits distinct from Lynx1. Lypd6 is an important regulator of embryogenesis in zebrafish through its enhancement of Wnt/Î²âcatenin signaling (Ãzhan <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0043" ref-type="ref">2013</xref>), and Lypd6 knockdown in mice results in small litter size and lack of ability to procreate, suggesting impaired germ cell or embryonic development (Darvas <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0014" ref-type="ref">2009</xref>). In humans, two distinct microduplications of the 2q23.1 chromosomal region containing the Lypd6 gene resulted in severe intellectual disability and autistic features (Chung <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0011" ref-type="ref">2012</xref>). Transgenic overâexpression of Lypd6 in mice increases the Ca<sup>2+</sup> component of nicotineâinduced currents in dissociated trigeminal ganglion neurons and results in behaviors indicative of an increased cholinergic tone, such as locomotor arousal, hypoalgesia, and preâpulse inhibition of the acoustic startle response (Darvas <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0014" ref-type="ref">2009</xref>). This invites the possibility that Lypd6, like Lynx1 and Lynx2, modulates nAChR function by binding to nAChRs. However, to the best of our knowledge, there is no report of interactions of Lynx proteins with native nAChRs in the human brain.</p>
    <p>Nicotine, the major pharmacologically active chemical found in tobacco smoke, is another important regulator of the cholinergic system through its modulation of nAChRs in animals and humans. Preâ or perinatal exposure to smoking or nicotine alone can produce longâterm alterations in several transmitter systems including the glutamatergic, serotonergic, and dopaminergic (Wang <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0057" ref-type="ref">2011</xref>; Muneoka <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0040" ref-type="ref">1997</xref>) and is associated with development of anxiety, attention deficit hyperactivity disorder, memory deficits, and other cognitive deficits [reviewed in (BloodâSiegfried and Rende <xref rid="jnc13718-bib-0007" ref-type="ref">2010</xref>; Abbott and WinzerâSerhan <xref rid="jnc13718-bib-0001" ref-type="ref">2012</xref>; Clifford <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0012" ref-type="ref">2012</xref>)].</p>
    <p>Here, we report for the first time a direct interaction of Lypd6 with native human nAChRs from fresh human temporal cortical extracts and we identify Lypd6 as an inhibitor of nAChR function in rat hippocampal slices and PC12 cells. Since Lypd6 and nicotine both modulate nAChRs and also regulate developmental processes, we further sought to examine a possible interaction between the two in a developmental model of nicotine exposure, and show that nicotine administration to pregnant rats alters Lypd6 protein levels in the brain of the adult offspring.</p>
    <sec id="jnc13718-sec-0002">
      <title>Materials and methods</title>
      <sec id="jnc13718-sec-0003">
        <title>Human tissue and animals</title>
        <p>Human temporal neocortical tissue was obtained from an anterior temporal lobectomy performed in a patient (female, age 58) with medically intractable temporal lobe epilepsy with hippocampal onset. Written informed consent was obtained before surgery. The study was approved by the Ethical Committee in the Capital Region of Denmark (Hâ2â2011â104) and performed in accordance with the Declaration of Helsinki. The tissue was immediately frozen on dry ice and stored at â80Â°C until use.</p>
        <p>Animal use for brain slice electrophysiology studies (Harlan Mice laboratories, Denmark) was permitted by the Animal Welfare Committee, appointed by the Danish Ministry of Justice and all experiments were in accordance with the institutional guidelines (The European Communities Council Directive of 24 November 1986 (86/609/EEC) and with Danish laws regulating experiments on animals.</p>
        <p>Pregnant dams and adult male SpragueâDawley (SD) rats (200â250Â g) were obtained from Charles River Laboratories (Germany), and housed individually or two per cage, respectively. For the experiment with perinatal nicotine exposure, timedâpregnant SD rats were obtained from Harlan Laboratories (Frederick, MD, USA). Pups were weaned at postânatal day (PND) 21. Only male pups were analyzed in this study. Animal procedures were conducted with approval of the Howard University Animal Care and Use Committee (HUâIACUC) adhering to the guidelines set forth by the National Research Council, or in accordance with the Danish National Guide for Care and Use of Laboratory animals and the European Communities Council Directive of 24 November 1986 (86/609/EEC).</p>
        <p>Mice deficient for the Î±7 or Î²2 nAChR subunit (C57BL/6J background), and wildâtype (WT) littermates were purchased from The Jackson Laboratories and bred at Virginia Commonwealth University. Mice deficient for the Î²4 nAChR subunit were obtained from Baylor University School of Medicine (Xu <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0060" ref-type="ref">1999</xref>), and subsequently maintained at the University of Colorado. Brains from 8 to 12Â weeks old male or female homozygous knockout (KO) and ageâ and sexâmatched wildâtype (WT) mice were used.</p>
        <p>Animals were kept on a 12/12Â h light/dark cycle provided with standard rodent diet and water <italic>adÂ libitum</italic>. The male animals were acclimatized for a minimum of 7Â days and the dams for about 24Â h after arrival before experiments began.</p>
      </sec>
      <sec id="jnc13718-sec-0004">
        <title>Developmental, tissue, cellular, and subcellular distribution of Lypd6</title>
        <p>Tissue crossâlinking using the cellâimpermeable crossâlinking agent bis(sulfosuccinimidyl) suberate (BS<sup>3</sup>, Pierce Biotechnology), fractionation into crude synaptosomes or soluble and membrane fractions, culturing of neuronal and astroâ and microglia cultures, as well as the developmental study and sampling of cerebrospinal fluid has been described previously for the same samples that are being used in this study (Thomsen <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0053" ref-type="ref">2014</xref>).</p>
      </sec>
      <sec id="jnc13718-sec-0005">
        <title>mRNA extraction and qPCR</title>
        <p>Total RNA was isolated using Trizol Reagent (SigmaâAldrich, St.Â Louis, MO, USA) according to the manufacturer's instructions. RNA samples were dissolved in RNaseâfree water and the RNA content was quantified using a Nanodrop NDâ1000 Spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA). Samples were diluted with RNaseâfree water to equal RNA concentrations and reverse transcribed into singleâstranded cDNA with Invitrogen<sup>TM</sup> SuperScript<sup>Â®</sup> III FirstâStrand Synthesis system (Thermo Fisher Scientific Inc., Waltham, MA, USA) according to the manufacturer's directions using 1.25Â Î¼M oligo (dT)<sub>20</sub> primers, 5Â mM MgCl<sub>2</sub>, and 2 units RNase inhibitor. Realâtime qPCR reactions were performed in a total volume of 20Â Î¼L, containing 5Â Î¼L sample cDNA, 1Ã Precision Plus qPCR Master mix, premixed with SYBRâgreen (Primerdesign, Southampton, UK), and 16 pmol of the forward and reverse primers (DNA technology, Aarhus, Denmark). PCR was performed on a Light Cycler<sup>Â®</sup> 480 RealâTime PCR System (Roche, Indianapolis, IN, USA) with a 2âmin preincubation at 95Â°C followed by 40 cycles of 15Â s at 95Â°C, 10Â s at 60Â°C, and 10Â s at 72Â°C. The primer pair for Lypd6 was (written 5â²â3â²): GCTACAAGATCTGCACCTCC and GCAAATGTGGCATCAGTGTC. Primer pairs were validated using serially diluted cDNA to establish a standard curve and by confirming the existence of a single product on a gel at the correct molecular weight. Quantification of mRNA expression was performed according to the comparative C<sub>T</sub> method as described by Schmittgen and Livak (<xref rid="jnc13718-bib-0047" ref-type="ref">2008</xref>). For each sample, the amount of target mRNA was normalized to the mean of the PND60 group.</p>
      </sec>
      <sec id="jnc13718-sec-0006">
        <title>Affinity purification</title>
        <p>Recombinant human GSTâtagged Lypd6 produced in E.coli (Cusabio, Wuhan, China) and dissolved to 1Â mg/mL in phosphateâbuffered saline (PBS), pH 7.4 was coupled to PureProteome<sup>â¢</sup> NHS Flexibind magnetic beads (Millipore, Billerica, MA, USA) in a ratio of 1Â :Â 2 (vol/vol) using the manufacturer's instructions. Successful coupling was confirmed by subsequent protein determination, showing a substantial decrease in the protein content of the Lypd6 solution. Another batch of beads without Lypd6 in the PBS was processed in parallel as a negative control. The beads were incubated in 0.1% bovine serum albumin in PBS, pH 7.4 for 1Â h at 4Â°C prior to use.</p>
        <p>Approximately, 100Â mg human temporal neocortical tissue was lysed in 1Â mL lysis buffer [50Â mM Tris, 50Â mM NaCl, 5Â mM EDTA, 5Â mM EGTA, 10Â Î¼L/mL protease inhibitor cocktail (SigmaâAldrich, BrÃ¸ndby, Denmark], pH 7.5) using a PT1200C polytron blender (Kinematica, Luzern, Switzerland) for 20Â s. The lysate was centrifuged for 30Â min at 160Â 000Â <italic>g</italic> at 20â22Â°C using an airâdriven ultracentrifuge (Airfuge<sup>Â®</sup>, Copenhagen, Denmark), and the supernatant was discarded. The pellet was resuspended in 1Â mL lysis buffer containing 2% Triton Xâ100 by blending for 20Â s and incubated for 2Â h at 4Â°C on a rotor (15Â rpm). Thereafter, the sample was centrifuged as above and the resulting supernatant (input) was used for affinity purification. Total protein content was determined using the Pierce 660Â nm Protein Assay (Thermo scientific, Rockford, IL, USA) and 700â1000Â Î¼g protein was incubated with 50Â Î¼L magnetic beads in a total volume of 1500Â Î¼L lysis buffer for 18â22Â h at 4Â°C on a rotor (15Â rpm). For experiments including Î±âbungarotoxin (Î±âBTX, Tocris Bioscience, Bristol, UK), the tissue was lysed in 10Â ml lysis buffer and centrifugation was performed in 4Â°C. A quantity of 100Â nM Î±âBTX (final concentration) or vehicle (PBS) was added to the tissue extracts followed by incubation for 30Â min on ice before addition of beads.</p>
        <p>Subsequently, a sample of the remaining homogenate after affinity purification was taken (output) and the beads were washed twice in 1Â M NaCl, 8Â mM Na<sub>2</sub>HPO<sub>4,</sub> 2Â mM NaH<sub>2</sub>PO<sub>4</sub>, 0.5% Triton Xâ100, pH 7.5, and thrice in 0.1Â M NaCl, 8Â mM Na<sub>2</sub>HPO<sub>4,</sub> 2Â mM NaH<sub>2</sub>PO<sub>4</sub>, 0.5% Triton Xâ100, pH 7.5, and immediately processed for western blotting.</p>
      </sec>
      <sec id="jnc13718-sec-0007">
        <title>PC12 cell culture and ERK phosphorylation assay</title>
        <p>PC12 cells were maintained in 75Â cm<sup>2</sup> flasks coated with 5Â Î¼g/mL polyâLâlysine (SigmaâAldrich), in Dulbecco's modified Eagle medium (Gibco Life Technologies, Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% heatâinactivated horse serum, 5% fetal bovine serum, 25Â U/mL penicillin, 25Â Î¼g/mL streptomycin, 1Â mM sodium pyruvate, and 2Â mM glutamine at 37Â°C in a humidified incubator with 5% CO<sub>2</sub>. Cells were subculturedÂ every 3â4Â days by detachment with 0.25% trypsin in EDTA solution (Gibco Life Technologies) and reâseeded at 15% confluence.</p>
        <p>For the extracellular signalâregulated kinase (ERK) phosphorylation assay, cells were seeded in 24âwell plates at 12Â ÃÂ 10<sup>4</sup> cells/cm<sup>2</sup>, 24Â h prior to the experiment. On the day of the experiment, cells were incubated for 10Â min with recombinant human Lypd6 protein or Î±âconotoxins PIA, MII, or AuIB (Tocris Bioscience) diluted in Dulbecco's modified Eagle medium, followed by 5âmin stimulation with 25Â Î¼Î nicotine (SigmaâAldrich). Thereafter, cells were lysed in 100Â Î¼L ice cold lysis buffer/well (100Â mM NaCl, 25Â mM EDTA, 10Â mM Tris, 4Â mM Na<sub>3</sub>VO<sub>4</sub>, 1Â mM NaF, and 1% (v/v) Triton Xâ100, 1% (v/v) NPâ40, 1Â Î¼L/mL protease inhibitor cocktail (SigmaâAldrich), pH 7.4). Ensure complete lysis, lysates were then placed in â80Â°C for 15Â min, thawed, and sonicated for 5Â s on ice. Lysates were stored at â80Â°C until use.</p>
      </sec>
      <sec id="jnc13718-sec-0008">
        <title>Nicotine administration</title>
        <p>Nicotine was administered to pregnant rats through a miniâosmotic infusion pump (Model #2006, Alzet, Cupertino, CA, USA) surgically implanted between the scapulae at gestational day 7, as previously described (Wang and GondrÃ©âLewis <xref rid="jnc13718-bib-0056" ref-type="ref">2013</xref>; Wang <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0057" ref-type="ref">2011</xref>). Nicotine hydrogen tartrate (SigmaâAldrich, St Louis, MO, USA) was prepared fresh on the day of pump implantation and delivered to dams at a rate of 4Â mg/kg/day (free base weight) from pregnancy until pups reached PND21. At PND21, the pups were weaned and allowed to reach adulthood (PND60). Hippocampus (HIP) and frontal cortex (FC) from male pups were microdissected and stored at â80Â°C for subsequent experimentation. Frontal cortical and hippocampal tissue from the left hemisphere were lysed for western blotting, and hippocampal tissue from the right hemisphere was used for BS<sup>3</sup> crossâlinking and synaptosome preparations as mentioned above. To study the effect of nicotine when administered directly to young and adult rats, 0.4Â mg/kg nicotine (free base weight) or vehicle (0.9% saline) was administered subcutaneously (s.c.) twice daily for 7Â days (PND8â14 or 54â60) and the FC and HIP were dissected 4Â h after the last administration.</p>
      </sec>
      <sec id="jnc13718-sec-0009">
        <title>Western blotting</title>
        <p>Total protein content was measured using a DC Protein Assay Kit (BioâRad, Hercules, CA, USA). Equal amounts of lysates were then diluted in a loading buffer (final concentration: 60Â mM Tris, 10% (v/v) glycerol, 5% (v/v) mercaptoethanol, 2% (w/v) sodium dodecyl sulfate, 0.025% (w/v) bromophenol blue, pH 6.8), incubated for 5Â min at 95Â°C, submitted to gel electrophoresis using AnykD<sup>â¢</sup> gels (BioâRad), and blotted onto polyvinylidene difluoride membranes (BioâRad). Membranes were washed in trisâbuffered saline with 0.1% Tween 20 (TBSâT) and blocked in TBS containing 5% (w/v) dry milk powder, which was also used for antibody incubations. Incubation in primary antisera against Lypd6 (1Â :Â 1000, #ARP53451_P050, Aviva Systems Biology, San Diego, CA, USA), Lynx1 (1Â :Â 1000, #scâ23060, Santa Cruz Biotechnology, Heidelberg, Germany), Ly6H (1Â :Â 1000, #H00004062âM01, Novus Biologicals, Cambridge, UK), Î±3, Î±4, Î±5, Î±6 (1Â :Â 100 #scâ1771, scâ5591, scâ28795, scâ27292 Santa Cruz Biotechnology) for which the selectivity has been previously characterized (Guan <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0022" ref-type="ref">2001</xref>; Lang <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0027" ref-type="ref">2003</xref>; Kabbani <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0026" ref-type="ref">2007</xref>; Yu <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0061" ref-type="ref">2007</xref>), Î²2 (1Â :Â 1000, provided by Dr Cecilia Gotti) and Î±7, Î²4 (1Â :Â 1000 #ab23832 and 1Â :Â 100 #ab156213 Abcam, Cambridge, UK) which we have validated in this study (Fig.Â S3), Actin (1Â :Â 10Â 000, #A5060, SigmaâAldrich), GluR2 (1Â :Â 200, #MABN71, Millipore), PSDâ95 (1Â :Â 2000, #ab9708, Millipore), phosphorylated ERK1/2 (1Â :Â 4000 #9101 Cell Signaling, Leiden, the Netherlands), or ERK1 (1Â :Â 4000, #610031, BD Transduction Laboratories, Franklin Lakes, NJ, USA) was done overnight at 4Â°C on parafilm in a humidified container, followed by 3Â ÃÂ 10Â min washes in TBSâT and 1Â h incubation at 20â22Â°C in horseradish peroxidaseâconjugated secondary antibody (1Â :Â 2000, Dako, Glostrup, Denmark). After thorough washing in TBSâT, enhanced chemiluminescence western blotting detection reagents (Western Lightning<sup>Â®</sup> ECL Pro, Perkin Elmer, Waltham, MA, USA) were used for signal detection and protein bands were visualized using an automated film developer (Colenta Labortechnik, Wiener Neustadt, Austria). Mean optical densities of bands were measured and their corresponding background measurement subtracted.</p>
      </sec>
      <sec id="jnc13718-sec-0010">
        <title>Brain slice preparation and electrophysiology</title>
        <p>Patch clamp, wholeâcell recordings were made from hippocampal CA1 interneurons in rat brain slices to determine the effects of Lypd6 on membrane current responses to nAChR agonists. Preparation of brain slices containing hippocampal CA1 neurons was conducted essentially as previously described (Soni and Kohlmeier <xref rid="jnc13718-bib-0048" ref-type="ref">2016</xref>). Briefly, 12â to 15âdayâold Naval Medical Research Institute (NMRI) wildâtype mice of either sex were anesthetized with isoflurane, decapitated, and the brain was rapidly removed and placed into an iceâcold (0â4Â°C) artificial cerebrospinal fluid (ACSF) which contained (in mM): 124 NaCl, 5 KCl, 1.2 Na<sub>2</sub>HPO<sub>4</sub>, 2.7 CaCl<sub>2</sub>, 1.2 MgSO<sub>4</sub>, 10 glucose, and 2.6 NaHCO<sub>3</sub>, bubbled with 95% O<sub>2</sub>/5% CO<sub>2</sub> resulting in a pH of 7.4. The block of the brain containing the HIP was sectioned into 250âÎ¼m thick coronal slices using a vibrotome (Leica VT 1200S, Leica, Germany) after vertical deflection was minimized. Thereafter, slices containing the HIP were incubated in ACSF at 37Â°C for ~20Â min followed by maintenance at 20â25Â°C for 1Â h to reach equilibration.</p>
        <p>All recordings were conducted in a submersion recording chamber at 20â25Â°C. Wholeâcell recordings were obtained from CA1 interneurons, identified visually using an upright microscope (Olympus BX51WI, Hamburg, Germany). Recording pipettes were made from borosilicate glass capillary tubing (1.5Â mm O.D), pulled on a horizontal puller (Sutter Instruments, Pâ95) and filled with internal patch solution (resistance of ~6Â MÎ) containing: (in mM) 144Â K gluconate, 3 MgCl<sub>2</sub>, 10 HEPES, 0.3 NaGTP, and 4 Na<sub>2</sub>ATP (295â300Â mOsM). Membrane currents were recorded using anÂ Axopatchâ200B amplifier (Axon Instruments) and were filtered at 2 KHz (lowâpass Bessel filter) at the amplifier output and digitized at 20Â KHz, with subsequent analysis of current amplitudes performed with Clampex 10.3 (Molecular Devices, Sunnyvale, CA, USA).</p>
        <p>Membrane responses induced by the activation of nAChRs on CA1 interneurons were recorded following application of nicotine (100Â Î¼M, Sigma, St. Louis, MO, USA), or the nAChR agonist, Dimethylphenylpiperazinium (DMPP) (50Â mM, Sigma), in the absence or presence of human recombinant Lypd6 protein (6Â Î¼M, Cusabio). All agonists were applied from borosilicate micropipettes ( ~2Â MÎ©) using pressure delivered via a picospritzer III (Parker Hannifin Corporation, Mayfield Heights, OH, USA) at a distance of â¤Â 100Â Î¼m from the recorded soma, with a constant pressure maintained at 10Â psi for 10â50Â ms. Lypd6 was also applied using a borosilicate micropipette ( ~500Â KÎ©) using pressure delivered via a picospritzer III at a distance of ~200Â Î¼m from recorded somas, with a constant pressure maintained at 10 psi for a duration of 4â5Â s. During Lypd6 application, bath perfusion of ACSF was stopped for 3â4Â min in order to maximize the diffusion of Lypd6 into the slice. To check the specificity of Lypd6âdependent effects on nAChR responses, the order of drug application was reversed in a few recordings, such that slices were exposed to Lypd6, then nAChR agonists were applied.</p>
      </sec>
      <sec id="jnc13718-sec-0011">
        <title>Statistical analysis</title>
        <p>Data were analyzed using twoâway <sc>anova</sc> with Sidakâcorrected multiple comparisons or Bonferroniâcorrected ratio paired <italic>t</italic>âtests. For the electrophysiological recordings, data were analyzed using unpaired or paired <italic>t</italic>âtests. The statistical calculations were performed using GraphPad Prism version 6 for Windows (GraphPad Software, San Diego, CA, USA). All data are presented as meanÂ Â±Â standard error of the mean, and a <italic>p</italic>âvalue of &lt;Â 0.05 was considered statistically significant.</p>
      </sec>
    </sec>
    <sec id="jnc13718-sec-0012">
      <title>Results</title>
      <sec id="jnc13718-sec-0013">
        <title>Distribution and developmental expression of Lypd6</title>
        <p>To characterize the expression pattern of Lypd6, we analyzed Lypd6 protein levels in different organs of adult male rats using western blotting. A band corresponding to Lypd6 protein was detected in all organs analyzed with high levels in the cortex and cerebellum of the brain, moderate levels in the lung, kidney, and liver, and low levels in the heart and prostate (Fig.Â <xref rid="jnc13718-fig-0001" ref-type="fig">1</xref>a). In the kidney, the Lypd6 antibody detected an additional lower molecular weight band.</p>
        <fig fig-type="Figure" xml:lang="en" id="jnc13718-fig-0001" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Distribution and developmental expression of Lypd6. (aâe) Representative images and analysis of western blots showing Lypd6 protein levels in: (a) different organs of adult male rats (<italic>n</italic>Â =Â 2) in relation to actin, (b) cortical tissue from adult male rats, rat cortical primary neurons cultured for 7 or 14Â days <italic>inÂ vitro</italic> (neuron <styled-content style="fixed-case">DIV</styled-content>7 and 14, respectively), rat primary microglia cultured for 15Â days <italic>inÂ vitro</italic>, and rat primary astroglia cultured for 18Â days <italic>inÂ vitro</italic> (<italic>nÂ </italic>=<italic>Â </italic>3) in relation to actin, (c) cerebrospinal fluid (<styled-content style="fixed-case">CSF</styled-content>), and soluble and membrane fractions of cortical tissue from adult male rats. The membraneâbound proteins, <styled-content style="fixed-case">PSD</styled-content>â95 and GluR2, and the soluble protein extracellular signalâregulated kinase 1 (<styled-content style="fixed-case">ERK</styled-content>) are used as controls for effective fractionation (<italic>n</italic>Â =Â 4), (d) <styled-content style="fixed-case">FC</styled-content> and <styled-content style="fixed-case">HIP</styled-content> tissue fractionated using differential centrifugation into a pellet 1 (P1, nuclear) and pellet 2 (P2, crude synaptosome) fraction. Data are normalized to actin levels and the level of the nonâfractionated homogenate (Hom) was set to 1 (dashed line). *<italic>pÂ </italic>&lt;<italic>Â </italic>0.05, **<italic>pÂ </italic>&lt;<italic>Â </italic>0.01 indicates statistical difference between nonâfractionated homogenate and the P2 fraction, <sup>#</sup>
<italic>pÂ </italic>&lt;<italic>Â </italic>0.05 indicates statistical difference between the P1 and P2 fractions in a Bonferroniâcorrected ratio paired <italic>t</italic>âtest (<italic>nÂ </italic>=<italic>Â </italic>5), (e) minced tissue extracts from the <styled-content style="fixed-case">FC</styled-content> or <styled-content style="fixed-case">HIP</styled-content> of adult male rats crossâlinked with bis(sulfosuccinimidyl) suberate (<styled-content style="fixed-case">BS</styled-content>
<sup>3</sup>) or vehicle (Veh). The staining for GluR2 shows that crossâlinking with <styled-content style="fixed-case">BS</styled-content>
<sup>3</sup> reduces the intensity of the GluR2 band at 95 <styled-content style="fixed-case">kD</styled-content>a, and produces a smear of highâmolecular weight crossâlinked proteins. Data are normalized to actin levels and the vehicle group was set to 1. **<italic>pÂ </italic>&lt;<italic>Â </italic>0.01, ***<italic>pÂ </italic>&lt;<italic>Â </italic>0.001 indicates statistical difference between vehicleâ and <styled-content style="fixed-case">BS</styled-content>
<sup>3</sup>âtreated tissue in a Bonferroniâcorrected ratioÂ paired <italic>t</italic>âtest (<italic>n</italic>Â =Â 9â11). (f) Lypd6 <styled-content style="fixed-case">mRNA</styled-content> levels in frontal cortex (<styled-content style="fixed-case">FC</styled-content>) and hippocampus (<styled-content style="fixed-case">HIP</styled-content>) from male rats killed at postânatal day 1, 7, 14, 26, 42, or 60 (<italic>n</italic>Â =Â 5â6). The values were normalized to <styled-content style="fixed-case">GAPDH</styled-content> levels.</p>
          </caption>
          <graphic id="nlm-graphic-5" xlink:href="JNC-138-806-g001"/>
        </fig>
        <p>We further detected high levels of endogenous Lypd6 protein in rat primary cortical neurons cultured to 14Â DIV (Fig.Â <xref rid="jnc13718-fig-0001" ref-type="fig">1</xref>b). Cortical neurons cultured to 7 DIV and astroglia cultured to 18Â DIV displayed moderate staining, whereas Lypd6 was not detectable in primary microglia cultured to 15Â DIV.</p>
        <p>Previous studies have shown that Lynx proteins are not only expressed as GPIâanchored membrane proteins but may also exist as soluble proteins (Adermann <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0003" ref-type="ref">1999</xref>; Bamezai <xref rid="jnc13718-bib-0006" ref-type="ref">2004</xref>). Fractionation of rat cortical tissue into soluble and membrane fractions by ultracentrifugation and subsequent western blotting alongside samples of rat cerebrospinal fluid (CSF) revealed that Lypd6 was detectable in the membrane fraction, but not in the soluble fraction or in CSF samples (Fig.Â <xref rid="jnc13718-fig-0001" ref-type="fig">1</xref>c). To validate the separation, we demonstrated that the membraneâassociated scaffolding protein, postâsynaptic density 95 (PSDâ95), and the Î±âaminoâ3âhydroxyâ5âmethylisoxazoleâ4âpropionate receptor subunit GluR2 were only present in the membrane fraction, whereas the soluble protein ERK1 was only present in the soluble fraction.</p>
        <p>To determine the subcellular localization of Lypd6, tissue homogenates from the FC and HIP were fractionated into nuclear (P1) and synaptosomal (P2) fractions (Fig.Â <xref rid="jnc13718-fig-0001" ref-type="fig">1</xref>d). There was a significantly higher level of Lypd6 in the HIP synaptosomal fraction compared to the total homogenate (<italic>pÂ </italic>&lt;<italic>Â </italic>0.01). Additionally, comparing the synaptosomal and nuclear/endosomal fractions revealed a significantly higher level of Lypd6 in synaptosomes in both the FC and HIP (both <italic>pÂ </italic>&lt;<italic>Â </italic>0.05). GluR2 was used as a positive control as it is known to be located in the synaptosomal fraction (Srivastava <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0049" ref-type="ref">1998</xref>).</p>
        <p>To determine the extent of surface expression of Lypd6, protein levels in tissue extracts from the FC or HIP of adult rats, crossâlinked using the cellâimpermeable protein crossâlinking agent BS<sup>3</sup>, were compared with untreated extracts (Fig.Â <xref rid="jnc13718-fig-0001" ref-type="fig">1</xref>e), and the GluR2 receptor subunit was used as a positive control and reference value (Grosshans <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0021" ref-type="ref">2002</xref>; Mielke and Mealing <xref rid="jnc13718-bib-0032" ref-type="ref">2009</xref>; Carino <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0010" ref-type="ref">2012</xref>). In the HIP, the Lypd6 signal was reduced by 42Â Â±Â 0.07% (meanÂ Â±Â SEM, <italic>pÂ </italic>&lt;<italic>Â </italic>0.01) compared to nonâcrossâlinked tissue extracts, corresponding to 87% of the signal reduction seen with GluR2, showing that Lypd6 is predominantly present on the cell surface. In the FC, the Lypd6 signal was reduced by 24Â Â±Â 0.11%, but was not significantly different from vehicle controls.</p>
        <p>We finally studied the expression pattern of Lypd6 during development. We measured Lypd6 mRNA levels in the FC and HIP of rats at PND1, 7, 14, 26, 42, and 60 (Fig.Â <xref rid="jnc13718-fig-0001" ref-type="fig">1</xref>f). Lypd6 mRNA was present in the FC at birth, but decreased to PND26 with a slower decrease from PND26 until PND60. In the hippocampal formation, Lypd6 mRNA was detected at high levels at birth and the levels decreased to near adult levels within the first three postânatal weeks.</p>
        <p>Taken together, these data indicate that Lypd6 is a membraneâbound protein, predominantly expressed in the rodent brain and highly enriched at the synaptic loci.</p>
      </sec>
      <sec id="jnc13718-sec-0014">
        <title>Lypd6 binds to multiple nAChRs in human brain extracts</title>
        <p>Members of the Lynx family have been demonstrated to bind to nAChRs altering their function (IbaÃ±ezâTallon <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0023" ref-type="ref">2002</xref>; Tekinay <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0051" ref-type="ref">2009</xref>; Jensen <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0025" ref-type="ref">2015</xref>). To test the binding of Lypd6 for nAChR subunits, we performed affinity purification using beadâcoupled recombinant human Lypd6 as bait. In extracts from human temporal cortex, Lypd6 was coâpurified with Î±3, Î±4, Î±5, Î±6, Î±7, Î²2, and Î²4 nAChR subunits (Fig.Â <xref rid="jnc13718-fig-0002" ref-type="fig">2</xref>a), but not with GluR2. None of the nAChR subunits were detected when the affinity purification was performed using nonâcoupled beads, confirming that coâpurification of nAChR subunits was attributable to a specific interaction with Lypd6. The selectivity of Î±7, Î²2, and Î²4 nAChR subunit antibodies used was verified by performing affinity purification with human recombinant Lypd6âcoupled beads on Î±7, Î²2, and Î²4 KO mice cortical tissue, showing that each of the subunits was only detected in the corresponding WT, but not KO homogenates (Fig.Â S3). Although quantitative assessment is not possible because of a low sample number, visual comparison of the input and output homogenates from the affinity purification suggest a reduction in band intensity for Î±4, Î±6, and Î±7, indicating that a detectable proportion of these nAChR subunits have been coâpurified by Lypd6.</p>
        <fig fig-type="Figure" xml:lang="en" id="jnc13718-fig-0002" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Lypd6 binds multiple <styled-content style="fixed-case">nAChR</styled-content> subunits in the human brain. (a) Cortical homogenates from human temporal cortex (input) were affinity purified using magnetic beads covalently coupled with recombinant human Lypd6 (Lypd6) or nonâcoupled beads (ctrl). Also shown is the remaining homogenate after affinity purification (output). Samples were submitted to gel electrophoresis and western blotting followed by detection of <styled-content style="fixed-case">nAChR</styled-content> subunits and the GluR2 <styled-content style="fixed-case">AMPA</styled-content> receptor subunit. (b) Representative images of western blots of Lypd6 affinity purification of human temporal cortex homogenates preâincubated with 100Â nM Î±â<styled-content style="fixed-case">BTX</styled-content> or vehicle [phosphateâbuffered saline (<styled-content style="fixed-case">PBS</styled-content>)] for 30Â min. (c) Quantification of data represented in (b), showing that Î±â<styled-content style="fixed-case">BTX</styled-content> interferes with binding of the Î±7 <styled-content style="fixed-case">nAChR</styled-content> subunit to Lypd6âcoupled beads (<italic>n</italic>Â =Â 5). Values are normalized to their individual vehicle and represented as meanÂ Â±Â <styled-content style="fixed-case">SEM</styled-content>. **<italic>pÂ </italic>&lt;<italic>Â </italic>0.01 indicates statistical difference from affinity purification in the absence of Î±â<styled-content style="fixed-case">BTX</styled-content> in a ratio paired <italic>t</italic>âtest.</p>
          </caption>
          <graphic id="nlm-graphic-7" xlink:href="JNC-138-806-g002"/>
        </fig>
        <p>Preâincubation of human temporal cortical extracts with the Î±7âspecific orthosteric antagonist Î±âBTX (100Â nM) significantly reduced the amount of the Î±7 nAChR subunit (26.8Â Â±Â 0.04%, <italic>pÂ </italic>&lt;<italic>Â </italic>0.01) isolated during the Lypd6 affinity purification compared to preâincubation with PBS, whereas it did not significantly affect the amount of Î±3, Î±4, Î±5, Î±6, Î²2, or Î²4 purified (Fig.Â <xref rid="jnc13718-fig-0002" ref-type="fig">2</xref>b and c). These results suggest that Lypd6 is able to interact with several nAChR subunits in the human cortex, and that Lypd6 competes with Î±âBTX for binding to the Î±7 nAChR.</p>
      </sec>
      <sec id="jnc13718-sec-0015">
        <title>Lypd6 regulates nicotineâinduced ERK phosphorylation</title>
        <p>To further assess the functional effect of Lypd6 binding to nAChRs, we used rat pheochromocytoma PC12 cells that natively express nAChRs (Nakayama <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0041" ref-type="ref">2006</xref>). Stimulation with 25Â Î¼M nicotine significantly increased phosphorylation of the MAP kinase ERK in PC12 cells. This increase was completely inhibited by preâincubation with 4Â Î¼M recombinant human Lypd6 (Fig.Â <xref rid="jnc13718-fig-0003" ref-type="fig">3</xref>). Lower concentrations of recombinant Lypd6 (0.04 and 0.4Â Î¼M) also slightly reduced ERK phosphorylation, but this did not reach significance. Lypd6 exposure alone did not affect basal levels of ERK phosphorylation. We have previously shown that the effect of nicotine on ERK phosphorylation in the PC12 cell line we used here is dependent on Î±3Î²4âcontaining nAChRs (Arvaniti <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0005" ref-type="ref">2015</xref>).</p>
        <fig fig-type="Figure" xml:lang="en" id="jnc13718-fig-0003" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Lypd6 inhibits nicotineâinduced <styled-content style="fixed-case">ERK</styled-content> phosphorylation. (a) Preâincubation for 10Â min with 4Â Î¼M recombinant human Lypd6 reduces nicotineâinduced <styled-content style="fixed-case">ERK</styled-content> phosphorylation in <styled-content style="fixed-case">PC</styled-content>12 cells, after stimulation with 25Â Î¼M nicotine for 5Â min. (b) Representative images of a western blot membrane summarized in (a), where the phosphorylated isoforms p44 and p42 of the <styled-content style="fixed-case">MAP</styled-content> kinase <styled-content style="fixed-case">ERK</styled-content> (<styled-content style="fixed-case">ERK</styled-content>1/2) are represented in the top panel (<styled-content style="fixed-case">pERK</styled-content>), whereas the total amount of unphosphorylated <styled-content style="fixed-case">ERK</styled-content> 1/2 is indicated in the bottom panel (tot<styled-content style="fixed-case">ERK</styled-content>). **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001 indicates statistical difference from the nicotine group in a oneâway ANOVA test.</p>
          </caption>
          <graphic id="nlm-graphic-9" xlink:href="JNC-138-806-g003"/>
        </fig>
      </sec>
      <sec id="jnc13718-sec-0016">
        <title>Lypd6 attenuates nicotineâinduced hippocampal inward currents</title>
        <p>Wholeâcell recordings were obtained from visually identified hippocampal CA1 interneurons (Freund and BuzsÃ¡ki <xref rid="jnc13718-bib-0018" ref-type="ref">1996</xref>; Alkondon and Albuquerque <xref rid="jnc13718-bib-0004" ref-type="ref">2001</xref>) of stratum oriens and stratum radiatum, where these interneurons have horizontally oriented spindleâshaped cell bodies and this feature is characteristically distinct from pyramidal neuronsÂ (Fig.Â <xref rid="jnc13718-fig-0004" ref-type="fig">4</xref>a). Hippocampal interneurons where chosen because of the abundant expression of the Î±7 nAChR subtype (Frazier <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0017" ref-type="ref">1998</xref>; Buhler and Dunwiddie <xref rid="jnc13718-bib-0008" ref-type="ref">2001</xref>, <xref rid="jnc13718-bib-0009" ref-type="ref">2002</xref>).</p>
        <fig fig-type="Figure" xml:lang="en" id="jnc13718-fig-0004" orientation="portrait" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Lypd6 reversibly attenuates <styled-content style="fixed-case">nAChR</styled-content>âinduced membrane responses in <styled-content style="fixed-case">CA</styled-content>1 hippocampal interneurons. (a) Bright field image of the stratum radiatum of the <styled-content style="fixed-case">CA</styled-content>1 hippocampal region where recordings were conducted (white arrow indicates recorded cell). Lypd6 (6Â Î¼M) was applied via a 2nd patch pipette (black arrow) close to the recorded cell and nicotine was applied via a 3rd pipette (gray arrow). Higher magnification image of a <styled-content style="fixed-case">CA</styled-content>1 interneuron recorded for this study (white arrow). The electrode delivering nicotine is also visible (gray arrow). (b) Wholeâcell voltage clamp recordings from a <styled-content style="fixed-case">CA</styled-content>1 interneuron showing no effect on induction of inward current by application of Lypd6. (c) An example of wholeâcell voltage clamp recordings from a <styled-content style="fixed-case">CA</styled-content>1 interneuron showing induction of inward current by application of nicotine (arrow) and attenuation of this current when applied in the presence of Lypd6 (Nic + Lypd6). Nicotine responses were not attenuated with a 3âmin interval between applications, indicating that reductions induced in the presence of Lypd6 were not because of cell run down, but were specific to the presence of the protein. (d) An example of wholeâcell voltage clamp recordings from a <styled-content style="fixed-case">CA</styled-content>1 interneuron, preâincubated in Lypd6 for 5Â min before first application of nicotine, showing that the effect of Lypd6 is lost upon washâout. The recording examples shown in (c) and (d) are not representing the mean values, but were rather chosen as highâamplitude samples to clearly demonstrate the inhibitory effect of Lypd6. (e) Graphs of mean responses to nicotine (n<sub>cells</sub>Â =Â 5) and to the nonâsubtypeâspecific <styled-content style="fixed-case">nAChR</styled-content> agonist <styled-content style="fixed-case">DMPP</styled-content> (n<sub>cells</sub>Â =Â 3) from the population of cells recorded, indicating that when Lypd6 is present, the amplitude of inward currents induced by activation of <styled-content style="fixed-case">nAChR</styled-content>s is significantly reduced. Data are displayed as each cell's response to the agonist in the presence of Lypd6 normalized to the same cell's response before the addition of Lypd6. Values are represented as meanÂ Â±Â <styled-content style="fixed-case">SEM</styled-content>. *<italic>pÂ </italic>&lt;<italic>Â </italic>0.05, **<italic>pÂ </italic>&lt;<italic>Â </italic>0.01, indicates statistical difference between groups in a paired <italic>t</italic>âtest.</p>
          </caption>
          <graphic id="nlm-graphic-11" xlink:href="JNC-138-806-g004"/>
        </fig>
        <p>Lypd6, when applied alone, did not induce an outward or inward membrane current (Fig.Â <xref rid="jnc13718-fig-0004" ref-type="fig">4</xref>b). When held at â60Â mV, nicotine application (100Â Î¼M, 10â50Â ms duration) resulted in an inward current of 67.2Â Â±Â 22.0 pA, which was repeatable with an interval of at least 3Â min between nicotine applications (<italic>n</italic>Â =Â 5, Fig.Â <xref rid="jnc13718-fig-0004" ref-type="fig">4</xref>c and d). In the presence of Lypd6 (6Â Î¼M), the average reduction in nicotineâinduced inward currents in each individual neuron was 57.4Â Â±Â 15.2% (meanÂ Â±Â SEM, paired <italic>t</italic>âtest, <italic>pÂ </italic>&lt;<italic>Â </italic>0.01, <italic>n</italic>
<sub>cells</sub>Â =Â 5, Fig.Â <xref rid="jnc13718-fig-0004" ref-type="fig">4</xref>e). Similarly, the nonâspecific nAChR agonist, DMPP (50Â Î¼M) induced an average inward current of 29.7Â Â±Â 7.2 pA, which was attenuated by 74.8Â Â±Â 12.6% when DMPP was applied in the presence of Lypd6 (n<sub>cells</sub>Â =Â 3, <italic>t</italic>âtest, <italic>pÂ </italic>&lt;<italic>Â </italic>0.05; Fig.Â <xref rid="jnc13718-fig-0004" ref-type="fig">4</xref>e).</p>
        <p>We further examined whether Lypd6âmediated attenuation of inward currents was because of order effects, or run down of nAChR responses because of cellular exhaustion. After preâincubation with Lypd6, nicotine was applied repeatedly, with a recovery time in between applications of ~Â 3Â min (Fig.Â <xref rid="jnc13718-fig-0004" ref-type="fig">4</xref>d). A gradual increase in the amplitude of nicotineâinduced inward currents was noted, suggesting that the observed effect was associated only with the presence of Lypd6 and could be reversed.</p>
      </sec>
      <sec id="jnc13718-sec-0017">
        <title>Perinatal nicotine exposure increases Lypd6 levels</title>
        <p>We analyzed the protein levels of Lypd6, Lynx1, and Ly6H at PND7, 21, and 60 in the FC and HIP of male rats exposed to continuous infusion of nicotine via osmoticÂ minipumps implanted into the pregnant dams (Fig.Â <xref rid="jnc13718-fig-0005" ref-type="fig">5</xref>a and b).</p>
        <fig fig-type="Figure" xml:lang="en" id="jnc13718-fig-0005" orientation="portrait" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Perinatal nicotine exposure increases hippocampal Lypd6 levels. (a) Quantification of Lypd6, Lynx1, and Ly6H protein levels as well as the Î²2 <styled-content style="fixed-case">nAChR</styled-content> subunit from frontal cortex (<styled-content style="fixed-case">FC</styled-content>) and hippocampus (<styled-content style="fixed-case">HIP</styled-content>) of male rats exposed to nicotine from embryonic day 7 to postânatal day (<styled-content style="fixed-case">PND</styled-content>) 21 through osmotic minipumps implanted into pregnant dams. Animals were killed at <styled-content style="fixed-case">PND</styled-content>7 (<italic>n</italic>Â =Â 5), 21 (<italic>n</italic>Â =Â 10), or 60 (<italic>n</italic>Â =Â 13). Main effect of nicotine treatment in a twoâway <sc>anova</sc> with age and treatment as the fixed factors is indicated in the graphs. *<italic>pÂ </italic>&lt;<italic>Â </italic>0.05 indicates statistical difference in a Sidakâcorrected multiple comparisons test. (b) Representative western blot images of protein levels from <styled-content style="fixed-case">FC</styled-content> and <styled-content style="fixed-case">HIP</styled-content> at the different ages. (c) Quantification of Lypd6 and GluR2 protein levels in hippocampal tissue from the P60 groups described (a), showing that perinatal nicotine exposure increases hippocampal Lypd6 levels in nuclear/endosomal fractions. Tissue was fractionated using differential centrifugation into a pellet 1 (P1, nuclear) and pellet 2 (P2, crude synaptosome) fraction or crossâlinked with bis(sulfosuccinimidyl) suberate (<styled-content style="fixed-case">BS</styled-content>
<sup>3</sup>). Data are normalized to actin levels and the level of the untreated, nonâfractionated homogenate was set to 1 (dashed line). *<italic>pÂ </italic>&lt;<italic>Â </italic>0.05, **<italic>pÂ </italic>&lt;<italic>Â </italic>0.01, ***<italic>pÂ </italic>&lt;<italic>Â </italic>0.001 indicates statistical difference from homogenate in a ratio paired <italic>t</italic>âtest, <sup>#</sup>
<italic>pÂ </italic>&lt;<italic>Â </italic>0.05 indicates statistical difference between vehicleâ and nicotineâtreated groups in an unpaired tâtest. (d) Representative western blot images of protein levels shown in (c).</p>
          </caption>
          <graphic id="nlm-graphic-13" xlink:href="JNC-138-806-g005"/>
        </fig>
        <p>A twoâway <sc>anova</sc> with age and treatment as the fixed factors revealed a significant main effect of nicotine treatment on Lypd6 levels in the HIP (<italic>pÂ </italic>&lt;<italic>Â </italic>0.01), but did not reach significance in the FC (<italic>pÂ </italic>=<italic>Â </italic>0.07). A subsequent Sidakâcorrected multiple comparison on HIP samples showed that nicotine significantly increased Lypd6 levels at PND60 (Fig.Â <xref rid="jnc13718-fig-0005" ref-type="fig">5</xref>a). A main effect of nicotine was also demonstrated on Î²2 levels in the FC (<italic>pÂ </italic>&lt;<italic>Â </italic>0.01), where a multiple comparisons test showed a significant effect of nicotine on Î²2 levels at PND21. Twoâway <sc>anova</sc>s on Lynx1 or Ly6H levels showed no significant main effect of nicotine.</p>
        <p>To further characterize the effect of nicotine on hippocampal Lypd6 levels, we demonstrate that nicotine administration significantly increased Lypd6 levels in the putative nuclear fraction (P1, <italic>pÂ </italic>&lt;<italic>Â </italic>0.05), whereas there was no difference between the groups in synaptosomal fractions (P2) or on Lypd6 surface levels, as measured using BS<sup>3</sup> crossâlinking of proteins (Fig.Â <xref rid="jnc13718-fig-0005" ref-type="fig">5</xref>c). To validate the methods, we show that GluR2 is reduced by crossâlinking and increased in synaptosomes in the two groups. Administration of nicotine (0.4Â mg/kg s.c. twice daily for 7Â days) to young or adult rats, did not alter protein levels of Lypd6, Lynx1, or Ly6H in the FC or HIP (Fig.Â <xref rid="jnc13718-fig-0006" ref-type="fig">6</xref>).</p>
        <fig fig-type="Figure" xml:lang="en" id="jnc13718-fig-0006" orientation="portrait" position="float">
          <label>Figure 6</label>
          <caption>
            <p>Shortâterm nicotine exposure does not alter Lypd6, Lynx1, or Ly6H levels in the brain. Lypd6, Lynx1, Ly6H, and Î²2 <styled-content style="fixed-case">nAChR</styled-content> subunit protein levels were analyzed in (a) frontal cortex (<styled-content style="fixed-case">FC</styled-content>) and hippocampal (<styled-content style="fixed-case">HIP</styled-content>) tissue from rats administered nicotine (0.4Â mg/kg s.c., twice daily) or vehicle (0.9% saline) for 7Â days from day 8â14 or (b) 54â60 (<italic>n</italic>Â =Â 8). (c and d) Representative images of western blots summarized in (a) and (b), respectively.</p>
          </caption>
          <graphic id="nlm-graphic-15" xlink:href="JNC-138-806-g006"/>
        </fig>
        <p>Moreover, Lypd6, Lynx1, and Ly6H protein levels in FC from wildâtype and Î²2, Î±7, or Î²4 knockout mice were compared using unpaired tâtests. No significant differences were found after genetic deletion of these nAChR subunits (Fig.Â <xref rid="jnc13718-fig-0007" ref-type="fig">7</xref>).</p>
        <fig fig-type="Figure" xml:lang="en" id="jnc13718-fig-0007" orientation="portrait" position="float">
          <label>Figure 7</label>
          <caption>
            <p>Knockout of <styled-content style="fixed-case">nAChR</styled-content> subunits does not alter Lypd6, Lynx1, or Ly6H levels in frontal cortex. Quantification of Lypd6, Lynx1, and Ly6H protein levels from <styled-content style="fixed-case">FC</styled-content> of mice that were either wildâtype (<styled-content style="fixed-case">WT</styled-content>) or had a genetic deletion knockout (<styled-content style="fixed-case">KO</styled-content>) of the Î²2 (<italic>n</italic>Â =Â 7â8), Î±7 (<italic>n</italic>Â =Â 7â8), or Î²4 (<italic>n</italic>Â =Â 4) <styled-content style="fixed-case">nAChR</styled-content> subunit gene. Data are normalized to actin levels and the level of the respective <styled-content style="fixed-case">WT</styled-content> was set to 1. Unpaired <italic>t</italic>âtests revealed no significant differences between <styled-content style="fixed-case">WT</styled-content> and KO mice.</p>
          </caption>
          <graphic id="nlm-graphic-17" xlink:href="JNC-138-806-g007"/>
        </fig>
      </sec>
    </sec>
    <sec id="jnc13718-sec-0018">
      <title>Discussion</title>
      <p>Here, we show that recombinant Lypd6 binds to multiple nAChR subunits in the human brain and inhibits nicotineâmediated activation of nAChRs <italic>inÂ vitro</italic>. Furthermore, perinatal nicotine administration leads to increased hippocampal Lypd6 protein levels in adulthood. These results suggest that Lypd6 modifies cholinergic neurotransmission by a direct interaction with mature nAChRs in the brain, and that this regulation may be altered by maternal exposure to nicotine.</p>
      <sec id="jnc13718-sec-0019">
        <title>Lypd6 is situated to regulate neurotransmission in the brain</title>
        <p>Lypd6 protein was detectable in all organs examined and had a high expression in the brain. The ubiquitous expression of Lypd6 protein is in accordance with Lypd6 mRNA expression in human and mouse organs (Darvas <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0014" ref-type="ref">2009</xref>; Zhang <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0062" ref-type="ref">2010</xref>). In primary cultures, Lypd6 is expressed by neurons and astroglia, but not by microglia. We have previously demonstrated that the Lynx proteins, Lynx1 and Ly6H, are exclusively expressed in neurons (Thomsen <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0053" ref-type="ref">2014</xref>), but other Lynx proteins have also been detected in glia (Cray <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0013" ref-type="ref">1990</xref>; Rogers <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0046" ref-type="ref">1996</xref>; Tanaka <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0050" ref-type="ref">1997</xref>; Mildner <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0033" ref-type="ref">2007</xref>).</p>
        <p>Lynx proteins may exist as GPIâanchored membrane proteins or soluble proteins (Adermann <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0003" ref-type="ref">1999</xref>; Bamezai <xref rid="jnc13718-bib-0006" ref-type="ref">2004</xref>). We detected Lypd6 in membrane fractions, but not soluble fractions or CSF samples and found that Lypd6 was predominantly localized to synaptosomes in the rat cortex, suggesting that Lypd6 is a membrane protein involved in synaptic function. This is in line with <italic>in silico</italic> analysis of the <italic>Lypd6</italic> gene in zebrafish, showing that it contains a possible GPIâattachment site, as well as studies in both zebrafish embryos and a mammalian cell line, showing that Lypd6 is GPIâanchored on the cell membrane (Ãzhan <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0043" ref-type="ref">2013</xref>). In contrast, other members of the Lynx family such as the prostate stem cell antigen are detected only in the soluble fraction (Jensen <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0025" ref-type="ref">2015</xref>). This discrimination may underlie differences in the mode of action, as a soluble version of the Lynx protein Lynx1 has been shown to exert a distinctive phenotype compared to the fullâlength form, when expressed in a transgenic mouse model (Miwa and Walz <xref rid="jnc13718-bib-0038" ref-type="ref">2012</xref>).</p>
        <p>We further found that Lypd6 mRNA is highly expressed during early development, showing high levels in the first postânatal days in rat FC and HIP, followed by a decrease toward adulthood. Our results imply a potential crucial role for Lypd6 in early mammalian development and support previous data, showing Lypd6 to be essential in vertebrate embryogenesis, by being involved in mesoderm and neuroectoderm patterning in zebrafish gastrulation (Ãzhan <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0043" ref-type="ref">2013</xref>). In addition, the developmental expression pattern of several other Lynx proteins in the brain, such as Lynx1, Lynx2, or Ly6H, as well as the involvement of Lynx1 in the regulation of plasticity in the visual cortex further support a role of this protein family in development (Dessaud <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0016" ref-type="ref">2006</xref>; Morishita <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0039" ref-type="ref">2010</xref>; Thomsen <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0053" ref-type="ref">2014</xref>).</p>
      </sec>
      <sec id="jnc13718-sec-0020">
        <title>Lypd6 binds to and regulates nAChRs</title>
        <p>We detected coâpurification of Î±3, Î±4, Î±5, Î±6, Î±7, Î²2, and Î²4 nAChR subunits by affinity pullâdown from human cortical extracts, using recombinant human Lypd6. This is the first demonstration of a direct interaction between a Lynx protein and native nAChRs in the human brain. These data indicate that Lypd6 protein is able to bind to multiple nAChR subunits in the human brain, including the clinically relevant Î±7 nAChR [reviewed in (Thomsen and Mikkelsen <xref rid="jnc13718-bib-0052" ref-type="ref">2012</xref>)]. We have previously shown that a soluble version of Lynx1 also binds multiple nAChR subunits (Thomsen <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0054" ref-type="ref">2014</xref>), but this broad spectrum of binding is not a feature of all Lynx proteins, as SLURPâ1 has been shown, using the same method, to bind selectively to Î±7 nAChRs (Lyukmanova <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0029" ref-type="ref">2016</xref>).</p>
        <p>To specifically investigate the interaction between Lypd6 and the human Î±7 nAChR, we used Î±âBTX and showed that it can interfere with Î±7 binding to Lypd6. This suggests that Lypd6 binds orthosterically to Î±7 nAChRs, although we cannot exclude the possibility that binding of Î±âBTX leads to conformational changes on the Î±7 nAChR, changing its affinity for Lypd6. If indeed Lypd6 binds on the orthosteric site, it indicates that Lypd6 could act as an antagonist, rather than an allosteric modulator, of nAChR function. In contrast, Lynx1 does not compete with Î±âBTX for binding to human Î±7 nAChRs or with epibatidine for binding to Î±4Î²2 nAChRs, suggesting that it binds outside of the orthosteric binding site (Lyukmanova <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0028" ref-type="ref">2011</xref>).</p>
        <p>The direct binding between Lypd6 and nAChRs prompted us to ask whether this had an effect on nAChR function. We show that a soluble version of Lypd6 completely inhibits nicotineâinduced phosphorylation of ERK in PC12 cells and reversibly attenuates nicotineâinduced inward currents in hippocampal interneurons of rat brain slices. This is in line with previous studies, indicating a modulatory role of Lynx proteins on wholeâcell currents (Miwa <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0036" ref-type="ref">1999</xref>; IbaÃ±ezâTallon <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0023" ref-type="ref">2002</xref>; Puddifoot <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0045" ref-type="ref">2015</xref>; Wu <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0059" ref-type="ref">2015</xref>; Lyukmanova <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0029" ref-type="ref">2016</xref>). Notably, Lypd6 exposure did not affect the baseline membrane current or basal levels of ERK phosphorylation, suggesting that the inhibitory effect is specifically related to nAChR signaling and that Lypd6 is not able to activate nAChRs. Activation of the ERK/MAPK pathway by phosphorylation is an important step in the formation of Longâterm potentiation (LTP) and memory in the HIP (Adams and Sweatt <xref rid="jnc13718-bib-0002" ref-type="ref">2002</xref>), and nicotineâmediated enhancement of LTP in the HIP is dependent on ERK (Welsby <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0058" ref-type="ref">2009</xref>). In accordance with previous findings (Nakayama <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0041" ref-type="ref">2006</xref>), we have shown that this effect of nicotine in PC12 cells is dependent on Î±3Î²4âcontaining nAChRs (Arvaniti <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0005" ref-type="ref">2015</xref>), suggesting that Lypd6 affects the function of Î±3Î²4âcontaining nAChRs. This is not to say, however, that the effects of Lypd6 in the brain are restricted to Î±3Î²4âcontaining nAChRs.</p>
        <p>Our results suggest that Lypd6 can act as an endogenous orthosteric antagonist of nAChRs in the brain. This sets Lypd6 aside from other Lynx proteins, such as Lynx1 and Lynx2, which have been shown to bind to and negatively regulate the function of Î±7 and Î±4Î²2 nAChRs in heterologous expression systems (IbaÃ±ezâTallon <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0023" ref-type="ref">2002</xref>; Tekinay <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0051" ref-type="ref">2009</xref>), suggesting an allosteric mode of action. However, we have employed a soluble variant of Lypd6 that could possibly function differently than, or bind to sites otherwise unreachable by, endogenous GPIâanchored Lypd6 on nAChRs, as previously speculated for the soluble Lynx1 protein (Miwa and Walz <xref rid="jnc13718-bib-0038" ref-type="ref">2012</xref>).</p>
        <p>It has previously been shown that transgenic overâexpression of Lypd6 in mice increases nicotineâinduced calcium currents and enhances behaviors associated with cholinergic neurotransmission (Darvas <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0014" ref-type="ref">2009</xref>). Our finding that Lypd6 forms a stable complex with nAChRs suggests that these effects may be caused by a direct interaction between Lypd6 and nAChRs. The apparent discrepancy between an enhancement of calcium currents and a decrease in inward currents and phosphorylation of ERK by Lypd6 may be explained by the experimental setups. We have employed a short exposure to a soluble variant of Lypd6, which likely affects primarily surface nAChRs, and which might bind differently to nAChRs compared with endogenous Lypd6. Transgenic overâexpression of Lypd6, on the other hand, may have more complex effects, possibly involving chaperoning of nAChRs by Lypd6 in the endoplasmic reticulum, as has previously been demonstrated for the Lynx proteins Lynx1 and Ly6H (Nichols <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0042" ref-type="ref">2014</xref>; Puddifoot <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0045" ref-type="ref">2015</xref>). Lypd6 protein is primarily intracellular when overâexpressed in COSâ7 cells (Zhang <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0062" ref-type="ref">2010</xref>), which is in line with a potential intracellular function of Lypd6 after transgenic expression. We demonstrate that endogenous Lypd6 is predominantly located on the cell surface in the rat HIP, whereas this localization is not as pronounced in the FC. Given the potential opposing function of surface versus intracellular Lypd6, this differential subcellular distribution of Lypd6 may have a significant impact on the function of Lypd6 in different brain regions.</p>
      </sec>
      <sec id="jnc13718-sec-0021">
        <title>Nicotine regulates hippocampal Lypd6 levels</title>
        <p>Since nicotine and Lypd6 both affect nAChR function as well as early development, we found it pertinent to examine whether exposure to nicotine during development affected Lypd6 protein levels in the brain. Using an exposure paradigm known to result in stable plasma levels of nicotine corresponding to that found in light to moderate smokers (Matta <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0030" ref-type="ref">2007</xref>), we found that perinatal nicotine exposure to dams produced an almost twofold increase of Lypd6 in the HIP of the adult offspring, whereas there were no effects on the Lynx proteins Lynx1 and Ly6H. This suggests that nicotine has longâterm effects on Lypd6 expression.</p>
        <p>Maternal smoking during or after pregnancy can have longâterm detrimental effects on the development of the offspring and lead to lifelong impairments (BloodâSiegfried and Rende <xref rid="jnc13718-bib-0007" ref-type="ref">2010</xref>; Abbott and WinzerâSerhan <xref rid="jnc13718-bib-0001" ref-type="ref">2012</xref>; Clifford <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0012" ref-type="ref">2012</xref>). Preânatal nicotine exposure reduces hippocampal levels of phosphorylated ERK in rats, and this has been suggested to underlie the cognitive deficits observed after gestational nicotine exposure (Parameshwaran <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0044" ref-type="ref">2013</xref>). We find that Lypd6 inhibits nAChRâmediated ERK phosphorylation <italic>inÂ vitro</italic> and that perinatal nicotine administration increases Lypd6 levels, suggesting that decreased ERK phosphorylation after preânatal nicotine administration may be caused by increased inhibition of nAChRs by Lypd6. It is therefore possible that part of the detrimental effect of nicotine on the development of the offspring is because of dysregulation of Lypd6.</p>
        <p>We further showed that the increase in Lypd6 following nicotine exposure was primarily evident in a putative nuclear/endosomal fraction, but not in synaptosomes, suggesting that nicotine leads to a preferential increase in nonâsynaptic Lypd6. If Lypd6 is able to chaperone nAChRs, nicotine administration might therefore alter this chaperoning. The effect of nicotine on Lypd6 levels was not recapitulated by nicotine administration to young or adult rats, suggesting that Lypd6 is more susceptible to regulation by nicotine during early development.</p>
        <p>Nicotine administration upâregulates nAChRs in the brain, including the Î±3Î²4 subtype (Govind <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0020" ref-type="ref">2009</xref>; Mazzo <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0031" ref-type="ref">2013</xref>). We therefore hypothesized that the effect of nicotine exposure on Lypd6 protein levels was an indirect effect caused by upâregulation of nAChRs. However, genetic ablation of Î²2â, Î²4â, or Î±7âcontaining nAChRs did not affect Lypd6 levels, suggesting that decreasing the levels of the major nAChR subtypes in the brain does not affect Lypd6 protein levels. It is, however, shown that Lynx1 interacts preferentially with Î±4/Î±4 dimers in Î±4Î²2 nAChRs (Nichols <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0042" ref-type="ref">2014</xref>), and if Lypd6 preferentially binds to Î±/Î± interfaces as well, we cannot exclude a potential effect of nicotine via Î±âsubunit upâregulation, other than Î±7. In a further attempt to see whether cholinergic tone or physiological changes affected Lypd6 signaling, we investigated regulation of Lypd6 by environmental enrichment in mice as well as by acute or repeated exercise training (Fig.Â S1). Lypd6 levels were unchanged in these paradigms, suggesting at least some selectivity in the effect of nicotine on Lypd6 levels. Together with a lack of effect of knockout of nAChR subunits on Lypd6 levels, these data suggest that the effect of nicotine on Lypd6 is not dependent on nAChR levels or cholinergic tone in adult animals. It thus seems that the regulation of Lypd6 by nicotine is limited to a certain time window during early development.</p>
        <p>Wnt/Î²âcatenin signaling is not only important for early development but also regulates nAChR localization and synaptic plasticity in the adult <italic>C.Â elegans</italic> nervous system (Jensen <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0024" ref-type="ref">2012</xref>). Since both nicotine and Lypd6 protein can regulate the Wnt/Î²âcatenin pathway (Zhou <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0063" ref-type="ref">2013</xref>; Ãzhan <italic>etÂ al</italic>. <xref rid="jnc13718-bib-0043" ref-type="ref">2013</xref>), it is possible that nicotine affects Lypd6 levels via the Wnt/Î²âcatenin pathway.</p>
        <p>In summary, our results indicate that Lypd6 is an endogenous orthosteric antagonist of cholinergic signaling in the brain, and that it is dysregulated by nicotine exposure during early development. This suggests that part of the detrimental consequences of maternal nicotine exposure during and after gestation on development of the offspring may be because of dysregulation of Lypd6 levels.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supporting information</title>
      <supplementary-material content-type="local-data" id="jnc13718-sup-0001">
        <caption>
          <p>
<bold>FigureÂ S1.</bold> Exercise or environmental enrichment does not modify Lypd6, Lynx1, or Ly6H levels in the brain.</p>
          <p>
<bold>FigureÂ S2.</bold> Characterization of Lypd6 antibody.</p>
          <p>
<bold>FigureÂ S3.</bold> Î±7, Î²2, and Î²4 nAChRs antibodies validation.</p>
        </caption>
        <media xlink:href="JNC-138-806-s001.doc">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="jnc13718-sec-0022">
      <title>Acknowledgments and conflict of interest disclosure</title>
      <p>The authors thank Maria NÃ¸rnberg and Christine Andersen for providing technical assistance, Dr Michael J. Marks for kindly providing tissue from transgenic mice, and Dr Cecilia Gotti for kindly providing the Î²2 antiserum. This work was supported by the Danish Ministry of Science, Innovation and Higher Education, The Augustinus Foundation, Agnes and Pouls Friis Foundation, Fonden til LÃ¦gemiddelvidenskabens Fremme, the Danish Strategic Research Council (COGNITO), the Danish Council for Independent Research (DFFâ4183â00246), The Danish Ministry of Culture, the Lundbeck Foundation, the National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH), NS65035, and the National Institute of Alcohol Abuse and Alcoholism (NIAAA), NIH AA021262.</p>
      <p>All experiments were conducted in compliance with the ARRIVE guidelines. The authors have no conflict of interest to declare.</p>
    </ack>
    <ref-list content-type="cited-references" id="jnc13718-bibl-0001">
      <title>References</title>
      <ref id="jnc13718-bib-0001">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0001">
<string-name>
<surname>Abbott</surname>
<given-names>L. C.</given-names>
</string-name> and <string-name>
<surname>WinzerâSerhan</surname>
<given-names>U. H.</given-names>
</string-name> (<year>2012</year>) <article-title>Smoking during pregnancy: lessons learned from epidemiological studies and experimental studies using animal models</article-title>. <source>Crit. Rev. Toxicol.</source>
<volume>42</volume>, <fpage>279</fpage>â<lpage>303</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.3109/10408444.2012.658506">10.3109/10408444.2012.658506</ext-link>.<pub-id pub-id-type="pmid">22394313</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0002">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0002">
<string-name>
<surname>Adams</surname>
<given-names>J. P.</given-names>
</string-name> and <string-name>
<surname>Sweatt</surname>
<given-names>J. D.</given-names>
</string-name> (<year>2002</year>) <article-title>Molecular psychology: roles for the ERK MAP kinase cascade in memory</article-title>. <source>Annu. Rev. Pharmacol. Toxicol.</source>
<volume>42</volume>, <fpage>135</fpage>â<lpage>163</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1146/annurev.pharmtox.42.082701.145401">10.1146/annurev.pharmtox.42.082701.145401</ext-link>.<pub-id pub-id-type="pmid">11807168</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0003">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0003">
<string-name>
<surname>Adermann</surname>
<given-names>K.</given-names>
</string-name>, <string-name>
<surname>Wattler</surname>
<given-names>F.</given-names>
</string-name>, <string-name>
<surname>Wattler</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Heine</surname>
<given-names>G.</given-names>
</string-name>, <string-name>
<surname>Meyer</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Forssmann</surname>
<given-names>W. G.</given-names>
</string-name> and <string-name>
<surname>Nehls</surname>
<given-names>M.</given-names>
</string-name> (<year>1999</year>) <article-title>Structural and phylogenetic characterization of human SLURPâ1, the first secreted mammalian member of the Lyâ6/uPAR protein superfamily</article-title>. <source>Protein Sci.</source>
<volume>8</volume>, <fpage>810</fpage>â<lpage>819</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1110/ps.8.4.810">10.1110/ps.8.4.810</ext-link>.<pub-id pub-id-type="pmid">10211827</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0004">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0004">
<string-name>
<surname>Alkondon</surname>
<given-names>M.</given-names>
</string-name> and <string-name>
<surname>Albuquerque</surname>
<given-names>E. X.</given-names>
</string-name> (<year>2001</year>) <article-title>Nicotinic acetylcholine receptor alpha7 and alpha4beta2 Subtypes differentially control GABAergic input to CA1 neurons in rat hippocampus</article-title>. <source>J. Neurophysiol.</source>
<volume>86</volume>, <fpage>3043</fpage>â<lpage>3055</lpage>.<pub-id pub-id-type="pmid">11731559</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0005">
        <mixed-citation publication-type="book" id="jnc13718-cit-0005">
<string-name>
<surname>Arvaniti</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Mikkelsen</surname>
<given-names>J. D.</given-names>
</string-name> and <string-name>
<surname>Thomsen</surname>
<given-names>M. S.</given-names>
</string-name> (<year>2015</year>) <source>BetaâAmyloid and Lypd6 Compete for Binding to Nicotinic Acetylcholine Receptors in Human Brain Extracts</source>. <publisher-name>In Society for Neuroscience Annual Meeting</publisher-name>, <publisher-loc>Chicago, IL</publisher-loc>.</mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0006">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0006">
<string-name>
<surname>Bamezai</surname>
<given-names>A.</given-names>
</string-name> (<year>2004</year>) <article-title>Mouse Lyâ6 proteins and their extended family: markers of cell differentiation and regulators of cell signaling</article-title>. <source>Arch. Immunol. Ther. Exp. (Warsz)</source>
<volume>52</volume>, <fpage>255</fpage>â<lpage>266</lpage>.<pub-id pub-id-type="pmid">15467490</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0007">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0007">
<string-name>
<surname>BloodâSiegfried</surname>
<given-names>J.</given-names>
</string-name> and <string-name>
<surname>Rende</surname>
<given-names>E. K.</given-names>
</string-name> (<year>2010</year>) <article-title>The longâterm effects of prenatal nicotine exposure on neurologic development</article-title>. <source>J Midwifery Womens Health</source>
<volume>55</volume>, <fpage>143</fpage>â<lpage>152</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.jmwh.2009.05.006">10.1016/j.jmwh.2009.05.006</ext-link>.<pub-id pub-id-type="pmid">20189133</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0008">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0008">
<string-name>
<surname>Buhler</surname>
<given-names>A. V.</given-names>
</string-name> and <string-name>
<surname>Dunwiddie</surname>
<given-names>T. V.</given-names>
</string-name> (<year>2001</year>) <article-title>Regulation of the activity of hippocampal stratum oriens interneurons by Î±7 nicotinic acetylcholine receptors</article-title>. <source>Neuroscience</source>
<volume>106</volume>, <fpage>55</fpage>â<lpage>67</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1016/S0306-4522(01)00257-3">10.1016/S0306â4522(01)00257â3</ext-link>.<pub-id pub-id-type="pmid">11564416</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0009">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0009">
<string-name>
<surname>Buhler</surname>
<given-names>A. V.</given-names>
</string-name> and <string-name>
<surname>Dunwiddie</surname>
<given-names>T. V.</given-names>
</string-name> (<year>2002</year>) <article-title>Alpha 7 nicotinic acetylcholine receptors on GABAergic interneurons evoke dendritic and somatic inhibition of hippocampal neurons</article-title>. <source>J. Neurophysiol.</source>
<volume>87</volume>, <fpage>548</fpage>â<lpage>557</lpage>.<pub-id pub-id-type="pmid">11784770</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0010">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0010">
<string-name>
<surname>Carino</surname>
<given-names>C.</given-names>
</string-name>, <string-name>
<surname>Fibuch</surname>
<given-names>E. E.</given-names>
</string-name>, <string-name>
<surname>Mao</surname>
<given-names>L.âM.</given-names>
</string-name> and <string-name>
<surname>Wang</surname>
<given-names>J. Q.</given-names>
</string-name> (<year>2012</year>) <article-title>Dynamic loss of surfaceâexpressed AMPA receptors in mouse cortical and striatal neurons during anesthesia</article-title>. <source>J. Neurosci. Res.</source>
<volume>90</volume>, <fpage>315</fpage>â<lpage>323</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1002/jnr.22749">10.1002/jnr.22749</ext-link>.<pub-id pub-id-type="pmid">21932367</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0011">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0011">
<string-name>
<surname>Chung</surname>
<given-names>B. H.</given-names>
</string-name>, <string-name>
<surname>Mullegama</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Marshall</surname>
<given-names>C. R.</given-names>
</string-name>
<italic>etÂ al</italic> (<year>2012</year>) <article-title>Severe intellectual disability and autistic features associated with microduplication 2q23.1</article-title>. <source>Eur. J. Hum. Genet.</source>
<volume>20</volume>, <fpage>398</fpage>â<lpage>403</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1038/ejhg.2011.199">10.1038/ejhg.2011.199</ext-link>.<pub-id pub-id-type="pmid">22085900</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0012">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0012">
<string-name>
<surname>Clifford</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Lang</surname>
<given-names>L.</given-names>
</string-name> and <string-name>
<surname>Chen</surname>
<given-names>R.</given-names>
</string-name> (<year>2012</year>) <article-title>Effects of maternal cigarette smoking during pregnancy on cognitive parameters of children and young adults: a literature review</article-title>. <source>Neurotoxicol. Teratol.</source>
<volume>34</volume>, <fpage>560</fpage>â<lpage>570</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.ntt.2012.09.004">10.1016/j.ntt.2012.09.004</ext-link>.<pub-id pub-id-type="pmid">23022448</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0013">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0013">
<string-name>
<surname>Cray</surname>
<given-names>C.</given-names>
</string-name>, <string-name>
<surname>Keane</surname>
<given-names>R. W.</given-names>
</string-name>, <string-name>
<surname>Malek</surname>
<given-names>T. R.</given-names>
</string-name> and <string-name>
<surname>Levy</surname>
<given-names>R. B.</given-names>
</string-name> (<year>1990</year>) <article-title>Regulation and selective expression of Lyâ6A/E, a lymphocyte activation molecule, in the central nervous system</article-title>. <source>Brain Res. Mol. Brain Res.</source>
<volume>8</volume>, <fpage>9</fpage>â<lpage>15</lpage>.<pub-id pub-id-type="pmid">2166206</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0014">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0014">
<string-name>
<surname>Darvas</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Morsch</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Racz</surname>
<given-names>I.</given-names>
</string-name>, <string-name>
<surname>Ahmadi</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Swandulla</surname>
<given-names>D.</given-names>
</string-name> and <string-name>
<surname>Zimmer</surname>
<given-names>A.</given-names>
</string-name> (<year>2009</year>) <article-title>Modulation of the Ca2Â +Â  conductance of nicotinic acetylcholine receptors by Lypd6. European neuropsychopharmacology</article-title>: <source>Eur. Neuropsychopharmacol.</source>
<volume>19</volume>, <fpage>670</fpage>â<lpage>681</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.euroneuro.2009.03.007">10.1016/j.euroneuro.2009.03.007</ext-link>.<pub-id pub-id-type="pmid">19403274</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0015">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0015">
<string-name>
<surname>Demars</surname>
<given-names>M. P.</given-names>
</string-name> and <string-name>
<surname>Morishita</surname>
<given-names>H.</given-names>
</string-name> (<year>2014</year>) <article-title>Cortical parvalbumin and somatostatin GABA neurons express distinct endogenous modulators of nicotinic acetylcholine receptors</article-title>. <source>Mol. Brain</source>
<volume>7</volume>, <fpage>75</fpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1186/s13041-014-0075-9">10.1186/s13041â014â0075â9</ext-link>.<pub-id pub-id-type="pmid">25359633</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0016">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0016">
<string-name>
<surname>Dessaud</surname>
<given-names>E.</given-names>
</string-name>, <string-name>
<surname>SalaÃ¼n</surname>
<given-names>D.</given-names>
</string-name>, <string-name>
<surname>Gayet</surname>
<given-names>O.</given-names>
</string-name>, <string-name>
<surname>Chabbert</surname>
<given-names>M.</given-names>
</string-name> and <string-name>
<surname>deLapeyriÃ¨re</surname>
<given-names>O</given-names>
</string-name> (<year>2006</year>) <article-title>Identification of lynx2, a novel member of the Lyâ6/neurotoxin superfamily, expressed in neuronal subpopulations during mouse development</article-title>. <source>Mol. Cell Neurosci.</source>
<volume>31</volume>, <fpage>232</fpage>â<lpage>242</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.mcn.2005.09.010">10.1016/j.mcn.2005.09.010</ext-link>.<pub-id pub-id-type="pmid">16236524</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0017">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0017">
<string-name>
<surname>Frazier</surname>
<given-names>C. J.</given-names>
</string-name>, <string-name>
<surname>Rollins</surname>
<given-names>Y. D.</given-names>
</string-name>, <string-name>
<surname>Breese</surname>
<given-names>C. R.</given-names>
</string-name>, <string-name>
<surname>Leonard</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Freedman</surname>
<given-names>R.</given-names>
</string-name> and <string-name>
<surname>Dunwiddie</surname>
<given-names>T. V.</given-names>
</string-name> (<year>1998</year>) <article-title>Acetylcholine activates an alphaâbungarotoxinâsensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells</article-title>. <source>J. Neurosci.</source>
<volume>18</volume>, <fpage>1187</fpage>â<lpage>1195</lpage>.<pub-id pub-id-type="pmid">9454829</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0018">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0018">
<string-name>
<surname>Freund</surname>
<given-names>T. F.</given-names>
</string-name> and <string-name>
<surname>BuzsÃ¡ki</surname>
<given-names>G.</given-names>
</string-name> (<year>1996</year>) <article-title>Interneurons of the hippocampus</article-title>. <source>Hippocampus</source>
<volume>6</volume>, <fpage>347</fpage>â<lpage>470</lpage>. doi: <ext-link ext-link-type="doi" xlink:href="10.1002/(SICI)1098-1063">10.1002/(SICI)1098â1063</ext-link>(1996) 6:4Â &lt;Â 347:AIDâHIPO1Â &gt;Â 3.0.CO;2âI.<pub-id pub-id-type="pmid">8915675</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0019">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0019">
<string-name>
<surname>Fu</surname>
<given-names>X. W.</given-names>
</string-name>, <string-name>
<surname>Rekow</surname>
<given-names>S. S.</given-names>
</string-name> and <string-name>
<surname>Spindel</surname>
<given-names>E. R.</given-names>
</string-name> (<year>2012</year>) <article-title>The Lyâ6 protein, lynx1, is an endogenous inhibitor of nicotinic signaling in airway epithelium</article-title>. <source>Am. J. Physiol. Lung Cell. Mol. Physiol.</source>
<volume>303</volume>: <fpage>L661</fpage>â<lpage>L668</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1152/ajplung.00075.2012">10.1152/ajplung.00075.2012</ext-link>.<pub-id pub-id-type="pmid">22923641</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0020">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0020">
<string-name>
<surname>Govind</surname>
<given-names>A. P.</given-names>
</string-name>, <string-name>
<surname>Vezina</surname>
<given-names>P.</given-names>
</string-name> and <string-name>
<surname>Green</surname>
<given-names>W. N.</given-names>
</string-name> (<year>2009</year>) <article-title>Nicotineâinduced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction</article-title>. <source>Biochem. Pharmacol.</source>
<volume>78</volume>, <fpage>756</fpage>â<lpage>765</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.bcp.2009.06.011">10.1016/j.bcp.2009.06.011</ext-link>.<pub-id pub-id-type="pmid">19540212</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0021">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0021">
<string-name>
<surname>Grosshans</surname>
<given-names>D. R.</given-names>
</string-name>, <string-name>
<surname>Clayton</surname>
<given-names>D. A.</given-names>
</string-name>, <string-name>
<surname>Coultrap</surname>
<given-names>S. J.</given-names>
</string-name> and <string-name>
<surname>Browning</surname>
<given-names>M. D.</given-names>
</string-name> (<year>2002</year>) <article-title>LTP leads to rapid surface expression of NMDA but not AMPA receptors in adult rat CA1</article-title>. <source>Nat. Neurosci.</source>
<volume>5</volume>, <fpage>27</fpage>â<lpage>33</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1038/nn779">10.1038/nn779</ext-link>.<pub-id pub-id-type="pmid">11740502</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0022">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0022">
<string-name>
<surname>Guan</surname>
<given-names>Z.âZ.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</string-name>, <string-name>
<surname>Ravid</surname>
<given-names>R.</given-names>
</string-name> and <string-name>
<surname>Nordberg</surname>
<given-names>A.</given-names>
</string-name> (<year>2001</year>) <article-title>Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease</article-title>. <source>J. Neurochem.</source>
<volume>74</volume>, <fpage>237</fpage>â<lpage>243</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1046/j.1471-4159.2000.0740237.x">10.1046/j.1471â4159.2000.0740237.x</ext-link>.</mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0023">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0023">
<string-name>
<surname>IbaÃ±ezâTallon</surname>
<given-names>I.</given-names>
</string-name>, <string-name>
<surname>Miwa</surname>
<given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H. L.</given-names>
</string-name>, <string-name>
<surname>Adams</surname>
<given-names>N. C.</given-names>
</string-name>, <string-name>
<surname>Crabtree</surname>
<given-names>G. W.</given-names>
</string-name>, <string-name>
<surname>Sine</surname>
<given-names>S. M.</given-names>
</string-name> and <string-name>
<surname>Heintz</surname>
<given-names>N.</given-names>
</string-name> (<year>2002</year>) <article-title>Novel modulation of neuronal nicotinic acetylcholine receptors by association with the endogenous prototoxin lynx1</article-title>. <source>Neuron</source>
<volume>33</volume>, <fpage>893</fpage>â<lpage>903</lpage>.<pub-id pub-id-type="pmid">11906696</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0024">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0024">
<string-name>
<surname>Jensen</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Hoerndli</surname>
<given-names>F. J.</given-names>
</string-name>, <string-name>
<surname>Brockie</surname>
<given-names>P. J.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>R.</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>E.</given-names>
</string-name>, <string-name>
<surname>Maxfield</surname>
<given-names>D.</given-names>
</string-name>, <string-name>
<surname>Francis</surname>
<given-names>M. M.</given-names>
</string-name>, <string-name>
<surname>Madsen</surname>
<given-names>D. M.</given-names>
</string-name> and <string-name>
<surname>Maricq</surname>
<given-names>A. V.</given-names>
</string-name> (<year>2012</year>) <article-title>Wnt signaling regulates acetylcholine receptor translocation and synaptic plasticity in the adult nervous system</article-title>. <source>Cell</source>
<volume>149</volume>, <fpage>173</fpage>â<lpage>187</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.cell.2011.12.038">10.1016/j.cell.2011.12.038</ext-link>.<pub-id pub-id-type="pmid">22464329</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0025">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0025">
<string-name>
<surname>Jensen</surname>
<given-names>M. M.</given-names>
</string-name>, <string-name>
<surname>Arvaniti</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mikkelsen</surname>
<given-names>J.D</given-names>
</string-name>, <string-name>
<surname>Michalski</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Pinborg</surname>
<given-names>LH</given-names>
</string-name>, <string-name>
<surname>HÃ¤rtig</surname>
<given-names>W.</given-names>
</string-name> and <string-name>
<surname>Thomsen</surname>
<given-names>M.S.</given-names>
</string-name> (<year>2015</year>) <article-title>Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimer's disease</article-title>. <source>Neurobiol. Aging</source>. <volume>36</volume>, <fpage>1629</fpage>â<lpage>1638</lpage>.<pub-id pub-id-type="pmid">25680266</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0026">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0026">
<string-name>
<surname>Kabbani</surname>
<given-names>N.</given-names>
</string-name>, <string-name>
<surname>Woll</surname>
<given-names>M. P.</given-names>
</string-name>, <string-name>
<surname>Levenson</surname>
<given-names>R.</given-names>
</string-name>, <string-name>
<surname>Lindstrom</surname>
<given-names>J. M.</given-names>
</string-name> and <string-name>
<surname>Changeux</surname>
<given-names>J.âP.</given-names>
</string-name> (<year>2007</year>) <article-title>Intracellular complexes of the beta2 subunit of the nicotinic acetylcholine receptor in brain identified by proteomics</article-title>. <source>Proc. Natl Acad. Sci. USA</source>
<volume>104</volume>, <fpage>20570</fpage>â<lpage>20575</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1073/pnas.0710314104">10.1073/pnas.0710314104</ext-link>.<pub-id pub-id-type="pmid">18077321</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0027">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0027">
<string-name>
<surname>Lang</surname>
<given-names>P. M.</given-names>
</string-name>, <string-name>
<surname>Burgstahler</surname>
<given-names>R.</given-names>
</string-name>, <string-name>
<surname>Sippel</surname>
<given-names>W.</given-names>
</string-name>, <string-name>
<surname>Irnich</surname>
<given-names>D.</given-names>
</string-name>, <string-name>
<surname>SchlotterâWeigel</surname>
<given-names>B.</given-names>
</string-name> and <string-name>
<surname>Grafe</surname>
<given-names>P.</given-names>
</string-name> (<year>2003</year>) <article-title>Characterization of neuronal nicotinic acetylcholine receptors in the membrane of unmyelinated human CâFiber axons by inÂ vitro studies</article-title>. <source>J. Neurophysiol.</source>
<volume>90</volume>, <fpage>3295</fpage>â<lpage>3303</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1152/jn.00512.2003">10.1152/jn.00512.2003</ext-link>.<pub-id pub-id-type="pmid">12878715</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0028">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0028">
<string-name>
<surname>Lyukmanova</surname>
<given-names>E. N.</given-names>
</string-name>, <string-name>
<surname>Shenkarev</surname>
<given-names>Z. O.</given-names>
</string-name>, <string-name>
<surname>Shulepko</surname>
<given-names>M. A.</given-names>
</string-name>
<italic>etÂ al</italic> (<year>2011</year>) <article-title>NMR structure and action on nicotinic acetylcholine receptors of waterâsoluble domain of human LYNX1</article-title>. <source>J. Biol. Chem.</source>
<volume>286</volume>, <fpage>10618</fpage>â<lpage>10627</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1074/jbc.M110.189100">10.1074/jbc.M110.189100</ext-link>.<pub-id pub-id-type="pmid">21252236</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0029">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0029">
<string-name>
<surname>Lyukmanova</surname>
<given-names>E. N.</given-names>
</string-name>, <string-name>
<surname>Shulepko</surname>
<given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>Kudryavtsev</surname>
<given-names>D.</given-names>
</string-name>
<italic>etÂ al</italic> (<year>2016</year>) <article-title>Human secreted Lyâ6/uPAR related proteinâ1 (SLURPâ1) is a selective allosteric antagonist of Î±7 nicotinic acetylcholine receptor</article-title>. <source>PLoS ONE</source>
<volume>11</volume>, <fpage>e0149733</fpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1371/journal.pone.0149733">10.1371/journal.pone.0149733</ext-link>.<pub-id pub-id-type="pmid">26905431</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0030">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0030">
<string-name>
<surname>Matta</surname>
<given-names>S. G.</given-names>
</string-name>, <string-name>
<surname>Balfour</surname>
<given-names>D. J.</given-names>
</string-name>, <string-name>
<surname>Benowitz</surname>
<given-names>N. L.</given-names>
</string-name>
<italic>etÂ al</italic> (<year>2007</year>) <article-title>Guidelines on nicotine dose selection for inÂ vivo research</article-title>. <source>Psychopharmacology</source>
<volume>190</volume>, <fpage>269</fpage>â<lpage>319</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1007/s00213-006-0441-0">10.1007/s00213â006â0441â0</ext-link>.<pub-id pub-id-type="pmid">16896961</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0031">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0031">
<string-name>
<surname>Mazzo</surname>
<given-names>F.</given-names>
</string-name>, <string-name>
<surname>Pistillo</surname>
<given-names>F.</given-names>
</string-name>, <string-name>
<surname>Grazioso</surname>
<given-names>G.</given-names>
</string-name>, <string-name>
<surname>Clementi</surname>
<given-names>F.</given-names>
</string-name>, <string-name>
<surname>Borgese</surname>
<given-names>N.</given-names>
</string-name>, <string-name>
<surname>Gotti</surname>
<given-names>C.</given-names>
</string-name> and <string-name>
<surname>Colombo</surname>
<given-names>S. F.</given-names>
</string-name> (<year>2013</year>) <article-title>Nicotineâmodulated subunit stoichiometry affects stability and trafficking of Î±3Î²4 nicotinic receptor</article-title>. <source>J. Neurosci.</source>
<volume>33</volume>, <fpage>12316</fpage>â<lpage>12328</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1523/JNEUROSCI.2393-13.2013">10.1523/JNEUROSCI.2393â13.2013</ext-link>.<pub-id pub-id-type="pmid">23884938</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0032">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0032">
<string-name>
<surname>Mielke</surname>
<given-names>J. G.</given-names>
</string-name> and <string-name>
<surname>Mealing</surname>
<given-names>G. A. R.</given-names>
</string-name> (<year>2009</year>) <article-title>Cellular distribution of the nicotinic acetylcholine receptor alpha7 subunit in rat hippocampus</article-title>. <source>Neurosci. Res.</source>
<volume>65</volume>, <fpage>296</fpage>â<lpage>306</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.neures.2009.08.003">10.1016/j.neures.2009.08.003</ext-link>.<pub-id pub-id-type="pmid">19682509</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0033">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0033">
<string-name>
<surname>Mildner</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Schmidt</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>Nitsche</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Merkler</surname>
<given-names>D.</given-names>
</string-name>, <string-name>
<surname>Hanisch</surname>
<given-names>U.âK.</given-names>
</string-name>, <string-name>
<surname>Mack</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Heikenwalder</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>BrÃ¼ck</surname>
<given-names>W.</given-names>
</string-name>, <string-name>
<surname>Priller</surname>
<given-names>J.</given-names>
</string-name> and <string-name>
<surname>Prinz</surname>
<given-names>M.</given-names>
</string-name> (<year>2007</year>) <article-title>Microglia in the adult brain arise from Lyâ6ChiCCR2Â +Â  monocytes only under defined host conditions</article-title>. <source>Nat. Neurosci.</source>
<volume>10</volume>, <fpage>1544</fpage>â<lpage>1553</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1038/nn2015">10.1038/nn2015</ext-link>.<pub-id pub-id-type="pmid">18026096</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0034">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0034">
<string-name>
<surname>Miwa</surname>
<given-names>J. M.</given-names>
</string-name> and <string-name>
<surname>Walz</surname>
<given-names>A.</given-names>
</string-name> (<year>2012</year>) <article-title>Enhancement in motor learning through genetic manipulation of the Lynx1 gene</article-title>. <source>PLoS ONE</source>
<volume>7</volume>, <fpage>e43302</fpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1371/journal.pone.0043302">10.1371/journal.pone.0043302</ext-link>.<pub-id pub-id-type="pmid">23139735</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0035">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0035">
<string-name>
<surname>Miwa</surname>
<given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Stevens</surname>
<given-names>T. R.</given-names>
</string-name>, <string-name>
<surname>King</surname>
<given-names>S. L.</given-names>
</string-name>, <string-name>
<surname>Caldarone</surname>
<given-names>B. J.</given-names>
</string-name>, <string-name>
<surname>IbanezâTallon</surname>
<given-names>I.</given-names>
</string-name>, <string-name>
<surname>Xiao</surname>
<given-names>C.</given-names>
</string-name>, <string-name>
<surname>Fitzsimonds</surname>
<given-names>R. M.</given-names>
</string-name>, <string-name>
<surname>Pavlides</surname>
<given-names>C.</given-names>
</string-name>, <string-name>
<surname>Lester</surname>
<given-names>H. A.</given-names>
</string-name>, <string-name>
<surname>Picciotto</surname>
<given-names>M. R.</given-names>
</string-name>, <string-name>
<surname>Heintz</surname>
<given-names>N.</given-names>
</string-name> (<year>2006</year>) <article-title>The prototoxin lynx1 acts on nicotinic acetylcholine receptors to balance neuronal activity and survival inÂ vivo</article-title>. <source>Neuron</source>
<volume>51</volume>, <fpage>587</fpage>â<lpage>600</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.neuron.2006.07.025">10.1016/j.neuron.2006.07.025</ext-link>.<pub-id pub-id-type="pmid">16950157</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0036">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0036">
<string-name>
<surname>Miwa</surname>
<given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>IbanezâTallon</surname>
<given-names>I.</given-names>
</string-name>, <string-name>
<surname>Crabtree</surname>
<given-names>G. W.</given-names>
</string-name>, <string-name>
<surname>SÃ¡nchez</surname>
<given-names>R.</given-names>
</string-name>, <string-name>
<surname>Sali</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Role</surname>
<given-names>L. W.</given-names>
</string-name> and <string-name>
<surname>Heintz</surname>
<given-names>N.</given-names>
</string-name> (<year>1999</year>) <article-title>lynx1, an endogenous toxinâlike modulator of nicotinic acetylcholine receptors in the mammalian CNS</article-title>. <source>Neuron</source>
<volume>23</volume>, <fpage>105</fpage>â<lpage>114</lpage>.<pub-id pub-id-type="pmid">10402197</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0037">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0037">
<string-name>
<surname>Miwa</surname>
<given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Freedman</surname>
<given-names>R.</given-names>
</string-name> and <string-name>
<surname>Lester</surname>
<given-names>H. A.</given-names>
</string-name> (<year>2011</year>) <article-title>Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses</article-title>. <source>Neuron</source>
<volume>70</volume>, <fpage>20</fpage>â<lpage>33</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.neuron.2011.03.014">10.1016/j.neuron.2011.03.014</ext-link>.<pub-id pub-id-type="pmid">21482353</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0038">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0038">
<string-name>
<surname>Miwa</surname>
<given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Lester</surname>
<given-names>H. A.</given-names>
</string-name> and <string-name>
<surname>Walz</surname>
<given-names>A.</given-names>
</string-name> (<year>2012</year>) <article-title>Optimizing cholinergic tone through Lynx modulators of nicotinic receptors: implications for plasticity and nicotine addiction</article-title>. <source>Physiology</source> (Bethesda, Md.) <volume>27</volume>, <fpage>187</fpage>â<lpage>199</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1152/physiol.00002.2012">10.1152/physiol.00002.2012</ext-link>.<pub-id pub-id-type="pmid">22875450</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0039">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0039">
<string-name>
<surname>Morishita</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>Miwa</surname>
<given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Heintz</surname>
<given-names>N.</given-names>
</string-name> and <string-name>
<surname>Hensch</surname>
<given-names>T. K.</given-names>
</string-name> (<year>2010</year>) <article-title>Lynx1, a cholinergic brake, limits plasticity in adult visual cortex</article-title>. <source>Science</source> (New York, N.Y.) <volume>330</volume>, <fpage>1238</fpage>â<lpage>1240</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1126/science.1195320">10.1126/science.1195320</ext-link>.<pub-id pub-id-type="pmid">21071629</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0040">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0040">
<string-name>
<surname>Muneoka</surname>
<given-names>K.</given-names>
</string-name>, <string-name>
<surname>Ogawa</surname>
<given-names>T.</given-names>
</string-name>, <string-name>
<surname>Kamei</surname>
<given-names>K.</given-names>
</string-name>, <string-name>
<surname>Muraoka</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Tomiyoshi</surname>
<given-names>R.</given-names>
</string-name>, <string-name>
<surname>Mimura</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Kato</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>M. R.</given-names>
</string-name> and <string-name>
<surname>Takigawa</surname>
<given-names>M.</given-names>
</string-name> (<year>1997</year>) <article-title>Prenatal nicotine exposure affects the development of the central serotonergic system as well as the dopaminergic system in rat offspring: involvement of route of drug administrations</article-title>. <source>Brain Res. Dev. Brain Res.</source>
<volume>102</volume>, <fpage>117</fpage>â<lpage>126</lpage>.<pub-id pub-id-type="pmid">9298240</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0041">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0041">
<string-name>
<surname>Nakayama</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>Shimoke</surname>
<given-names>K.</given-names>
</string-name>, <string-name>
<surname>Isosaki</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Satoh</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>Yoshizumi</surname>
<given-names>M.</given-names>
</string-name> and <string-name>
<surname>Ikeuchi</surname>
<given-names>T.</given-names>
</string-name> (<year>2006</year>) <article-title>Subtypes of neuronal nicotinic acetylcholine receptors involved in nicotineâinduced phosphorylation of extracellular signalâregulated protein kinase in PC12Â h cells</article-title>. <source>Neurosci. Lett.</source>
<volume>392</volume>, <fpage>101</fpage>â<lpage>104</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.neulet.2005.09.003">10.1016/j.neulet.2005.09.003</ext-link>.<pub-id pub-id-type="pmid">16219421</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0042">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0042">
<string-name>
<surname>Nichols</surname>
<given-names>W. A.</given-names>
</string-name>, <string-name>
<surname>Henderson</surname>
<given-names>B. J.</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>C.</given-names>
</string-name>, <string-name>
<surname>Parker</surname>
<given-names>R. L.</given-names>
</string-name>, <string-name>
<surname>Richards</surname>
<given-names>C. I.</given-names>
</string-name>, <string-name>
<surname>Lester</surname>
<given-names>H. A.</given-names>
</string-name> and <string-name>
<surname>Miwa</surname>
<given-names>J. M.</given-names>
</string-name> (<year>2014</year>) <article-title>Lynx1 shifts a4Ã2 nicotinic receptor subunit stoichiometry by affecting assembly in the endoplasmic reticulum</article-title>. <source>J. Biol. Chem.</source>
<volume>289</volume>, <fpage>31423</fpage>â<lpage>31432</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1074/jbc.M114.573667">10.1074/jbc.M114.573667</ext-link>.<pub-id pub-id-type="pmid">25193667</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0043">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0043">
<string-name>
<surname>Ãzhan</surname>
<given-names>G.</given-names>
</string-name>, <string-name>
<surname>Sezgin</surname>
<given-names>E.</given-names>
</string-name>, <string-name>
<surname>Wehner</surname>
<given-names>D.</given-names>
</string-name>, <string-name>
<surname>Pfister</surname>
<given-names>A. S.</given-names>
</string-name>, <string-name>
<surname>KÃ¼hl</surname>
<given-names>S. J.</given-names>
</string-name>, <string-name>
<surname>KagermeierâSchenk</surname>
<given-names>B.</given-names>
</string-name>, <string-name>
<surname>KÃ¼hl</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Schwille</surname>
<given-names>P.</given-names>
</string-name> and <string-name>
<surname>Weidinger</surname>
<given-names>G.</given-names>
</string-name> (<year>2013</year>) <article-title>Lypd6 enhances Wnt/Î²âcatenin signaling by promoting Lrp6 phosphorylation in raft plasma membrane domains</article-title>. <source>Dev. Cell</source>
<volume>26</volume>, <fpage>331</fpage>â<lpage>345</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.devcel.2013.07.020">10.1016/j.devcel.2013.07.020</ext-link>.<pub-id pub-id-type="pmid">23987510</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0044">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0044">
<string-name>
<surname>Parameshwaran</surname>
<given-names>K.</given-names>
</string-name>, <string-name>
<surname>Buabeid</surname>
<given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>Bhattacharya</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Uthayathas</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Kariharan</surname>
<given-names>T.</given-names>
</string-name>, <string-name>
<surname>Dhanasekaran</surname>
<given-names>M.</given-names>
</string-name> and <string-name>
<surname>Suppiramaniam</surname>
<given-names>V.</given-names>
</string-name> (<year>2013</year>) <article-title>Long term alterations in synaptic physiology, expression of Ã2 nicotinic receptors and ERK1/2 signaling in the hippocampus of rats with prenatal nicotine exposure</article-title>. <source>Neurobiol. Learn. Mem.</source>
<volume>106</volume>, <fpage>102</fpage>â<lpage>111</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.nlm.2013.07.007">10.1016/j.nlm.2013.07.007</ext-link>.<pub-id pub-id-type="pmid">23871741</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0045">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0045">
<string-name>
<surname>Puddifoot</surname>
<given-names>C. A.</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Sung</surname>
<given-names>R.âJ.</given-names>
</string-name> and <string-name>
<surname>Joiner</surname>
<given-names>W. J.</given-names>
</string-name> (<year>2015</year>) <article-title>Ly6Â h regulates trafficking of alpha7 nicotinic acetylcholine receptors and nicotineâinduced potentiation of glutamatergic signaling</article-title>. <source>J. Neurosci.</source>
<volume>35</volume>, <fpage>3420</fpage>â<lpage>3430</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1523/JNEUROSCI.3630-14.2015">10.1523/JNEUROSCI.3630â14.2015</ext-link>.<pub-id pub-id-type="pmid">25716842</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0046">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0046">
<string-name>
<surname>Rogers</surname>
<given-names>C. A.</given-names>
</string-name>, <string-name>
<surname>Gasque</surname>
<given-names>P.</given-names>
</string-name>, <string-name>
<surname>Piddlesden</surname>
<given-names>S. J.</given-names>
</string-name>, <string-name>
<surname>Okada</surname>
<given-names>N.</given-names>
</string-name>, <string-name>
<surname>Holers</surname>
<given-names>V. M.</given-names>
</string-name> and <string-name>
<surname>Morgan</surname>
<given-names>B. P.</given-names>
</string-name> (<year>1996</year>) <article-title>Expression and function of membrane regulators of complement on rat astrocytes in culture</article-title>. <source>Immunology</source>
<volume>88</volume>, <fpage>153</fpage>â<lpage>161</lpage>.<pub-id pub-id-type="pmid">8707343</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0047">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0047">
<string-name>
<surname>Schmittgen</surname>
<given-names>T. D.</given-names>
</string-name> and <string-name>
<surname>Livak</surname>
<given-names>K. J.</given-names>
</string-name> (<year>2008</year>) <article-title>Analyzing realâtime PCR data by the comparative CT method</article-title>. <source>Nat. Protoc.</source>
<volume>3</volume>, <fpage>1101</fpage>â<lpage>1108</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1038/nprot.2008.73">10.1038/nprot.2008.73</ext-link>.<pub-id pub-id-type="pmid">18546601</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0048">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0048">
<string-name>
<surname>Soni</surname>
<given-names>N.</given-names>
</string-name> and <string-name>
<surname>Kohlmeier</surname>
<given-names>K. A.</given-names>
</string-name> (<year>2016</year>) <article-title>Endocannabinoid CB1 receptorâmediated rises in Ca2Â +Â  and depolarizationâinduced suppression of inhibition within the laterodorsal tegmental nucleus</article-title>. <source>Brain Struct. Funct.</source>
<volume>221</volume>, <fpage>1255</fpage>â<lpage>1277</lpage>.<pub-id pub-id-type="pmid">25573246</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0049">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0049">
<string-name>
<surname>Srivastava</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Osten</surname>
<given-names>P.</given-names>
</string-name>, <string-name>
<surname>Vilim</surname>
<given-names>F. S.</given-names>
</string-name>, <string-name>
<surname>Khatri</surname>
<given-names>L.</given-names>
</string-name>, <string-name>
<surname>Inman</surname>
<given-names>G.</given-names>
</string-name>, <string-name>
<surname>States</surname>
<given-names>B.</given-names>
</string-name>, <string-name>
<surname>Daly</surname>
<given-names>C.</given-names>
</string-name>
<italic>etÂ al</italic> (<year>1998</year>) <article-title>Novel anchorage of GluR2/3 to the postsynaptic density by the AMPA receptorâbinding protein ABP</article-title>. <source>Neuron</source>
<volume>21</volume>, <fpage>581</fpage>â<lpage>591</lpage>.<pub-id pub-id-type="pmid">9768844</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0050">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0050">
<string-name>
<surname>Tanaka</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Marunouchi</surname>
<given-names>T.</given-names>
</string-name> and <string-name>
<surname>Sawada</surname>
<given-names>M.</given-names>
</string-name> (<year>1997</year>) <article-title>Expression of Lyâ6C on microglia in the developing and adult mouse brain</article-title>. <source>Neurosci. Lett.</source>
<volume>239</volume>, <fpage>17</fpage>â<lpage>20</lpage>.<pub-id pub-id-type="pmid">9547161</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0051">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0051">
<string-name>
<surname>Tekinay</surname>
<given-names>A. B.</given-names>
</string-name>, <string-name>
<surname>Nong</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Miwa</surname>
<given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Lieberam</surname>
<given-names>I.</given-names>
</string-name>, <string-name>
<surname>IbanezâTallon</surname>
<given-names>I.</given-names>
</string-name>, <string-name>
<surname>Greengard</surname>
<given-names>P.</given-names>
</string-name> and <string-name>
<surname>Heintz</surname>
<given-names>N.</given-names>
</string-name> (<year>2009</year>) <article-title>A role for LYNX2 in anxietyârelated behavior</article-title>. <source>Proc. Natl Acad. Sci. USA</source>
<volume>106</volume>, <fpage>4477</fpage>â<lpage>4482</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1073/pnas.0813109106">10.1073/pnas.0813109106</ext-link>.<pub-id pub-id-type="pmid">19246390</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0052">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0052">
<string-name>
<surname>Thomsen</surname>
<given-names>M. S.</given-names>
</string-name> and <string-name>
<surname>Mikkelsen</surname>
<given-names>J. D.</given-names>
</string-name> (<year>2012</year>) <article-title>The Î±7 nicotinic acetylcholine receptor complex: one, two or multiple drug targets?</article-title>
<source>Curr. Drug Targets</source>
<volume>13</volume>, <fpage>707</fpage>â<lpage>720</lpage>.<pub-id pub-id-type="pmid">22300038</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0053">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0053">
<string-name>
<surname>Thomsen</surname>
<given-names>M. S.</given-names>
</string-name>, <string-name>
<surname>Cinar</surname>
<given-names>B.</given-names>
</string-name>, <string-name>
<surname>Jensen</surname>
<given-names>M. M.</given-names>
</string-name>, <string-name>
<surname>Lyukmanova</surname>
<given-names>E. N.</given-names>
</string-name>, <string-name>
<surname>Shulepko</surname>
<given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>Tsetlin</surname>
<given-names>V.</given-names>
</string-name>, <string-name>
<surname>Klein</surname>
<given-names>A. B.</given-names>
</string-name> and <string-name>
<surname>Mikkelsen</surname>
<given-names>J. D.</given-names>
</string-name> (<year>2014</year>) <article-title>Expression of the Lyâ6 family proteins Lynx1 and Ly6H in the rat brain is compartmentalized, cellâtype specific, and developmentally regulated</article-title>. <source>Brain Struct. Funct.</source>
<volume>219</volume>, <fpage>1923</fpage>â<lpage>1934</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1007/s00429-013-0611-x">10.1007/s00429â013â0611âx</ext-link>.<pub-id pub-id-type="pmid">23860910</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0054">
        <mixed-citation publication-type="book" id="jnc13718-cit-0054">
<string-name>
<surname>Thomsen</surname>
<given-names>M. S.</given-names>
</string-name>, <string-name>
<surname>Arvaniti</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Jensen</surname>
<given-names>M. M.</given-names>
</string-name>, <string-name>
<surname>Lyukmanova</surname>
<given-names>E. N.</given-names>
</string-name>, <string-name>
<surname>Shulepko</surname>
<given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>HÃ¤rtig</surname>
<given-names>W.</given-names>
</string-name>, <string-name>
<surname>Tsetlin</surname>
<given-names>V.</given-names>
</string-name> and <string-name>
<surname>Mikkelsen</surname>
<given-names>J. D.</given-names>
</string-name> (<year>2014</year>) <source>Lynx1 Interacts with Multiple Nicotinic Acetylcholine Receptor Subtypes in the Human Brain: Relation to Alzheimer's Diseaseâlike Pathology</source>. <publisher-name>In Society for Neuroscience Annual Meeting</publisher-name>, <publisher-loc>Washington, DC</publisher-loc>.</mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0500">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0500">
<string-name>
<surname>Thomsen</surname>
<given-names>M. S.</given-names>
</string-name>, <string-name>
<surname>Andreasen</surname>
<given-names>J. T.</given-names>
</string-name>, <string-name>
<surname>Arvaniti</surname>
<given-names>M.</given-names>
</string-name> and <string-name>
<surname>Kohlmeier</surname>
<given-names>K. A.</given-names>
</string-name> (<year>2016</year>) <article-title>Nicotinic Acetylcholine Receptors in the Pathophysiology of Al zheimer's Disease: The Role of ProteinâProtein Interactions in Current and Future Treatment</article-title>. <source>Curr. Pharm. Des.</source>
<volume>22</volume>, <fpage>2015</fpage>â<lpage>2034</lpage>.<pub-id pub-id-type="pmid">26818866</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0055">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0055">
<string-name>
<surname>Tsetlin</surname>
<given-names>V.</given-names>
</string-name> (<year>1999</year>) <article-title>Snake venom alphaâneurotoxins and other âthreeâfingerâ proteins</article-title>. <source>Eur. J. Biochem.</source>
<volume>264</volume>, <fpage>281</fpage>â<lpage>286</lpage>.<pub-id pub-id-type="pmid">10491072</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0056">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0056">
<string-name>
<surname>Wang</surname>
<given-names>H.</given-names>
</string-name> and <string-name>
<surname>GondrÃ©âLewis</surname>
<given-names>M. C.</given-names>
</string-name> (<year>2013</year>) <article-title>Prenatal nicotine and maternal deprivation stress deâregulate the development of CA1, CA3, and dentate gyrus neurons in hippocampus of infant rats</article-title>. <source>PLoS ONE</source>
<volume>8</volume>, <fpage>e65517</fpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1371/journal.pone.0065517">10.1371/journal.pone.0065517</ext-link>.<pub-id pub-id-type="pmid">23785432</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0057">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0057">
<string-name>
<surname>Wang</surname>
<given-names>H.</given-names>
</string-name>, <string-name>
<surname>DÃ¡vilaâGarcÃ­a</surname>
<given-names>M. I.</given-names>
</string-name>, <string-name>
<surname>Yarl</surname>
<given-names>W.</given-names>
</string-name> and <string-name>
<surname>GondrÃ©âLewis M</surname>
<given-names>C.</given-names>
</string-name> (<year>2011</year>) <article-title>Gestational nicotine exposure regulates expression of AMPA and NMDA receptors and their signaling apparatus in developing and adult rat hippocampus</article-title>. <source>Neuroscience</source>
<volume>188</volume>, <fpage>168</fpage>â<lpage>181</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.neuroscience.2011.04.069">10.1016/j.neuroscience.2011.04.069</ext-link>.<pub-id pub-id-type="pmid">21596105</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0058">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0058">
<string-name>
<surname>Welsby</surname>
<given-names>P. J.</given-names>
</string-name>, <string-name>
<surname>Rowan</surname>
<given-names>M. J.</given-names>
</string-name> and <string-name>
<surname>Anwyl</surname>
<given-names>R.</given-names>
</string-name> (<year>2009</year>) <article-title>Intracellular mechanisms underlying the nicotinic enhancement of LTP in the rat dentate gyrus</article-title>. <source>Eur. J. Neuorsci.</source>
<volume>29</volume>, <fpage>65</fpage>â<lpage>75</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1111/j.1460-9568.2008.06562.x">10.1111/j.1460â9568.2008.06562.x</ext-link>.</mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0059">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0059">
<string-name>
<surname>Wu</surname>
<given-names>M.</given-names>
</string-name>, <string-name>
<surname>Puddifoot</surname>
<given-names>C. A.</given-names>
</string-name>, <string-name>
<surname>Taylor</surname>
<given-names>P.</given-names>
</string-name> and <string-name>
<surname>Joiner</surname>
<given-names>W. J.</given-names>
</string-name> (<year>2015</year>) <article-title>Mechanisms of inhibition and potentiation of a4Ã2 nicotinic acetylcholine receptors by members of the Ly6 protein family</article-title>. <source>J. Biol. Chem.</source>
<volume>290</volume>, <fpage>24509</fpage>â<lpage>24518</lpage>.<pub-id pub-id-type="pmid">26276394</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0060">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0060">
<string-name>
<surname>Xu</surname>
<given-names>W.</given-names>
</string-name>, <string-name>
<surname>OrrâUrtreger</surname>
<given-names>A.</given-names>
</string-name>, <string-name>
<surname>Nigro</surname>
<given-names>F.</given-names>
</string-name>, <string-name>
<surname>Gelber</surname>
<given-names>S.</given-names>
</string-name>, <string-name>
<surname>Sutcliffe</surname>
<given-names>C. B.</given-names>
</string-name>, <string-name>
<surname>Armstrong</surname>
<given-names>D.</given-names>
</string-name>, <string-name>
<surname>Patrick</surname>
<given-names>J. W.</given-names>
</string-name>, <string-name>
<surname>Role</surname>
<given-names>L. W.</given-names>
</string-name> and <string-name>
<surname>Beaudet</surname>
<given-names>A. L.</given-names>
</string-name> and <string-name>
<surname>De Biasi</surname>
<given-names>M.</given-names>
</string-name> (<year>1999</year>) <article-title>Multiorgan autonomic dysfunction in mice lacking the beta2 and the beta4 subunits of neuronal nicotinic acetylcholine receptors</article-title>. <source>J. Neurosci.</source>
<volume>19</volume>, <fpage>9298</fpage>â<lpage>9305</lpage>.<pub-id pub-id-type="pmid">10531434</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0061">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0061">
<string-name>
<surname>Yu</surname>
<given-names>W.âF.</given-names>
</string-name>, <string-name>
<surname>Guan</surname>
<given-names>Z.âZ.</given-names>
</string-name> and <string-name>
<surname>Nordberg</surname>
<given-names>A.</given-names>
</string-name> (<year>2007</year>) <article-title>Postnatal upregulation of alpha4 and alpha3 nicotinic receptor subunits in the brain of alpha7 nicotinic receptorâdeficient mice</article-title>. <source>Neuroscience</source>
<volume>146</volume>, <fpage>1618</fpage>â<lpage>1628</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1016/j.neuroscience.2007.03.002">10.1016/j.neuroscience.2007.03.002</ext-link>.<pub-id pub-id-type="pmid">17434683</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0062">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0062">
<string-name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Lang</surname>
<given-names>Q.</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>J.</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>F.</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>B.</given-names>
</string-name> and <string-name>
<surname>Long</surname>
<given-names>Y.</given-names>
</string-name> (<year>2010</year>) <article-title>Identification and characterization of human LYPD6, a new member of the Lyâ6 superfamily</article-title>. <source>Mol. Biol. Rep.</source>
<volume>37</volume>, <fpage>2055</fpage>â<lpage>2062</lpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1007/s11033-009-9663-7">10.1007/s11033â009â9663â7</ext-link>.<pub-id pub-id-type="pmid">19653121</pub-id></mixed-citation>
      </ref>
      <ref id="jnc13718-bib-0063">
        <mixed-citation publication-type="journal" id="jnc13718-cit-0063">
<string-name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>B.</given-names>
</string-name>, <string-name>
<surname>Dong</surname>
<given-names>Z.</given-names>
</string-name>, <string-name>
<surname>Fen Liu</surname>
<given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y. Y.</given-names>
</string-name>, <string-name>
<surname>Shang</surname>
<given-names>F.</given-names>
</string-name>, <string-name>
<surname>Lizheng</surname>
<given-names>W.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X.</given-names>
</string-name> and <string-name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</string-name> (<year>2013</year>) <article-title>Nicotine deteriorates the osteogenic differentiation of periodontal ligament stem cells through Î±7 nicotinic acetylcholine receptor regulating Wnt pathway</article-title>. <source>PLoS ONE</source>
<volume>8</volume>, <fpage>e83102</fpage>. doi:<ext-link ext-link-type="doi" xlink:href="10.1371/journal.pone.0083102">10.1371/journal.pone.0083102</ext-link>.<pub-id pub-id-type="pmid">24376645</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>